# BugSigDB 2024-06-24_19:58_UTC, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/1/2_Colorectal-adenoma:conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/2/1_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	207244
bsdb:1/2/2_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_DOWN	NA	100883
bsdb:1/4/1_Colorectal-adenoma:Proximal-conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1485	836	162289	1301	165779	283168	207244	189330	40544	33024
bsdb:1/4/2_Colorectal-adenoma:Proximal-conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/5/1_Colorectal-adenoma:Distal-conventional-adenoma-cases_vs_controls_DOWN	NA	1485	1350
bsdb:1/6/1_Colorectal-adenoma:Non-advanced-conventional-adenoma-cases_vs_controls_UP	NA	1654	283168	1301	189330	40544	33024
bsdb:1/7/1_Colorectal-adenoma:advanced-conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	836	165779	150022	162289	724
bsdb:1/7/2_Colorectal-adenoma:advanced-conventional-adenoma-cases_vs_controls_DOWN	NA	140625	28050
bsdb:2/1/1_Head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_UP	NA	543311
bsdb:2/1/2_Head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_DOWN	NA	1654
bsdb:2/2/1_Head-and-neck-squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_UP	NA	543311
bsdb:2/2/2_Head-and-neck-squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_DOWN	NA	1654
bsdb:3/1/1_Colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_UP	NA	848	836
bsdb:4/1/1_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_UP	NA	469	838	29465	33024
bsdb:4/1/2_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_DOWN	NA	375288	1263	574697	1678	53246	39948
bsdb:5/1/1_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_UP	NA	46123	1654	642	653683	1380	1678	118747	830	194	1016	43996	82202	84162	893	39948	156973	1730	848	52228	32067	186650	1839	133925	265975	543311	1257	838	32207	970	613	123375	1301	195950	29465
bsdb:5/1/2_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1485	88138	2023	544	1663
bsdb:5/2/1_Chronic-obstructive-pulmonary-disease:Severe_vs_moderate-Chronic-obstructive-pulmonary-disease_UP	NA	1839	289201	1485	186650	642
bsdb:7/1/1_Autism:severely-autistic_vs_non-sibling-control_UP	NA	191303	816	286729	872	258514	375288
bsdb:7/1/2_Autism:severely-autistic_vs_non-sibling-control_DOWN	NA	114627	52784	109326	1678	1485	102106	39948	253238	31983	1578	1243	113286	1263	1301	46255
bsdb:10/1/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	437755
bsdb:10/2/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	1375
bsdb:14/1/1_Halitosis:Oral-Halitosis_vs_Control_UP	NA	194	195950	39948	1257	970	32067	2740	543311	157	1016	416916	838
bsdb:14/1/2_Halitosis:Oral-Halitosis_vs_Control_DOWN	NA	416916	724	437755	265975	838	1301	2740	32067
bsdb:15/1/1_Gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_UP	NA	33057
bsdb:15/1/2_Gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_DOWN	NA	55080	935200	1578	231454	44675
bsdb:16/1/1_Obesity:high-fat-diet_vs_normal-chow-diet_UP	NA	31980	1263	248744	239759	572511
bsdb:16/1/2_Obesity:high-fat-diet_vs_normal-chow-diet_DOWN	NA	816	283168	109326	574697	209	990721	35832	459786
bsdb:16/2/1_Obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_UP	NA	583	283168	209	109326	872	574697	239934	1920251
bsdb:16/2/2_Obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	239759	244127
bsdb:17/1/1_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	848	816	946234	1432051	1505663
bsdb:17/1/2_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	35832	580596	39948	216851	28050	46205	841	292632	40544
bsdb:17/2/1_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	1578	848	816	561	620	375288	1505663	946234
bsdb:17/2/2_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	244127	397864	580596	574697	102106	216851	1407607	28050	437755	846	577310	2740	841	292632
bsdb:18/1/1_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	244127	816	572511	830	1485	189330	1730	216851	1578	459786	1017280	841	1263	292632
bsdb:18/1/2_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	239934	239759	283168	375288	838	195950
bsdb:18/2/1_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	1485	841
bsdb:18/2/2_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	239934
bsdb:18/3/1_Obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_UP	NA	816
bsdb:18/3/2_Obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_DOWN	NA	239934	244127
bsdb:19/1/1_Schizophrenia:Schizophrenia_vs_Healthy-controls_UP	NA	838	83770	848	906	1578	544	33024	904	872
bsdb:19/1/2_Schizophrenia:Schizophrenia_vs_Healthy-controls_DOWN	NA	1301	33042	841	572511
bsdb:20/1/1_Non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_UP	NA	816
bsdb:20/1/2_Non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_DOWN	NA	838
bsdb:20/2/1_Non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_UP	NA	1263	816
bsdb:20/2/2_Non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_DOWN	NA	838
bsdb:21/1/1_Obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_UP	NA	838	102106	841	1301	39948
bsdb:21/1/2_Obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_DOWN	NA	816	375288	239759
bsdb:22/1/1_Parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	1578	990721	270497	119852	1678
bsdb:22/1/2_Parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	189330	816	838	216851
bsdb:23/1/1_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_UP	NA	239759	816	572511	1378	33024	35832
bsdb:23/1/2_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_DOWN	NA	447020	1678	1485	39948	86331
bsdb:24/1/1_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_UP	NA	331654	816	194	848	1378
bsdb:24/1/2_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	29465	724	836	475	286
bsdb:25/1/1_Psoriasis:Psoriasis-Male_vs_Female_UP	NA	1301	150022	165779	29465	360541	1716	43668	32207	33882	57495	1016	469	36739	171412
bsdb:25/1/2_Psoriasis:Psoriasis-Male_vs_Female_DOWN	NA	1578	1743	2701	212791	1696
bsdb:26/1/1_Sex-design:female_vs_male_UP	NA	35832
bsdb:26/2/1_Obesity:BMI->33-female_vs_male_UP	NA	816
bsdb:27/1/1_Obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_UP	NA	1485	191303	2740	946234	574697	580596	375288
bsdb:27/1/2_Obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_DOWN	NA	816	239759	397864	209	283168	872	174708	28138	1331051
bsdb:27/2/1_Obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_UP	NA	172900	256846	1485	28138	244127	459786	946234	1578	2740	574697	375288
bsdb:27/2/2_Obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_DOWN	NA	209	816	283168	1331051
bsdb:28/1/1_Chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_UP	NA	119852	84111	1357	244127	100883
bsdb:28/1/2_Chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_DOWN	NA	2740	724	1380	1485	216851	1263	416916	1678	102106	40544
bsdb:29/1/1_Unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	946234	574697	375288	239759
bsdb:29/1/2_Unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	216851	39948	1263	724	561	620
bsdb:29/2/1_Unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	574697
bsdb:29/2/2_Unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	1263	724	1485
bsdb:30/1/1_Chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_UP	NA	841	61170
bsdb:30/1/2_Chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_DOWN	NA	816	239759	397864	838	375288
bsdb:30/2/1_Chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_UP	NA	239759	420345
bsdb:30/2/2_Chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_DOWN	NA	841	61170	39948	84036
bsdb:30/3/1_Chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_UP	NA	420345
bsdb:30/3/2_Chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_DOWN	NA	553372
bsdb:31/1/1_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	207244	1485	100883	1017280
bsdb:31/1/2_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	33042	189330	216851	1378	724	841
bsdb:31/2/1_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	1485	207244
bsdb:31/2/2_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	33042	189330	216851	841
bsdb:31/3/1_Chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_UP	NA	1485	100883	84111	1017280	286
bsdb:31/3/2_Chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_DOWN	NA	189330
bsdb:32/1/2_Anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_DOWN	NA	1263	841	1485
bsdb:34/1/2_Bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:34/2/1_Bipolar-disorder:Bipolar-patients-with-high-IL-6_vs_low-IL-6_UP	NA	1578	1301
bsdb:34/4/1_Bipolar-disorder:Bipolar-patients-with-high-LDL_vs_low-LDL_DOWN	NA	838
bsdb:34/5/1_Bipolar-disorder:Bipolar-patients-with-high-TRP_vs_low-TRP_UP	NA	1578
bsdb:34/6/1_Bipolar-disorder:Bipolar-patients-with-high-TBARS-level_vs_low-TBARS-level_UP	NA	1730
bsdb:34/7/1_Bipolar-disorder:Bipolar-patients-with-high-MDA-level_vs_low-MDA-level_DOWN	NA	216851
bsdb:34/8/1_Bipolar-disorder:Bipolar-patients-with-high-BMI_vs_low-BMI_UP	NA	1578
bsdb:34/9/1_Bipolar-disorder:Bipolar-patients-with-metabolic-syndrome_vs_no-metabolic-syndrome_UP	NA	1578
bsdb:34/10/2_Bipolar-disorder:Bipolar-patients-with-depressive-syndrome_vs_healthier-bipolar-patients_DOWN	NA	841
bsdb:34/11/2_Bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:35/1/1_Sjogren-syndrome:PSS_vs_Controls_UP	NA	29465
bsdb:35/1/2_Sjogren-syndrome:PSS_vs_Controls_DOWN	NA	1654	724	482	32207	836	1257
bsdb:36/1/1_Obesity:obese-adolescent_vs_control-adult_UP	NA	1654
bsdb:36/1/2_Obesity:obese-adolescent_vs_control-adult_DOWN	NA	119852
bsdb:36/2/1_Obesity:obese-adult_vs_control-adolescent_UP	NA	1301
bsdb:36/2/2_Obesity:obese-adult_vs_control-adolescent_DOWN	NA	119852
bsdb:36/3/1_Obesity:control-adolescent_vs_control-adult_UP	NA	119852
bsdb:36/3/2_Obesity:control-adolescent_vs_control-adult_DOWN	NA	1301
bsdb:36/4/1_Obesity:obese-adolescent_vs_obese-adult_UP	NA	1654	447020
bsdb:36/5/1_Obesity:obese-adolescent_vs_control-adolescent_UP	NA	1654	447020	1301
bsdb:36/5/2_Obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	119852
bsdb:37/1/1_Colorectal-cancer:CRC-patients_vs_Healthy-controls_UP	NA	165779	194	1730	236752	848	1378	61170	32257	32067	283168	459786	375288	543311	1257	836	123375
bsdb:37/1/2_Colorectal-cancer:CRC-patients_vs_Healthy-controls_DOWN	NA	1243	1301
bsdb:38/1/1_Body-odor-measurement:head-of-teenager_vs_head-of-child_UP	NA	1912216
bsdb:38/1/2_Body-odor-measurement:head-of-teenager_vs_head-of-child_DOWN	NA	55193	1279
bsdb:38/2/1_Body-odor-measurement:teen-neck_vs_child-neck_UP	NA	1912216	55193
bsdb:38/2/2_Body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1279
bsdb:39/1/2_Body-odor-measurement:youth-underarm-after-exercise_vs_youth-underarm-before_DOWN	NA	265
bsdb:39/2/1_Body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:39/3/1_Body-odor-measurement:Children-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/4/1_Body-odor-measurement:Children-Neck-before_vs_after-excercise_UP	NA	1279
bsdb:39/4/2_Body-odor-measurement:Children-Neck-before_vs_after-excercise_DOWN	NA	1912216
bsdb:39/5/1_Body-odor-measurement:teen-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/6/1_Body-odor-measurement:teen-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:40/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	1678	84111	283168	375288	239759
bsdb:40/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	292632	1263	35829	33042
bsdb:41/1/1_Psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	2038	528	316625	56688	1578	53572	109262
bsdb:41/1/2_Psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	1163	96	35798
bsdb:42/1/1_Extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_UP	NA	1301	1350	1279	906	28100	158846
bsdb:42/1/2_Extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_DOWN	NA	1678	816	572511	216851	841	207244	102106
bsdb:43/1/1_Behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	1283313
bsdb:43/2/1_Behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	59735	838
bsdb:44/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	816
bsdb:45/1/1_Obesity:Rats-fed--HFHS_vs_control-rats_UP	NA	572511	1678	33024	174708
bsdb:46/1/1_Obesity:pediatric-obese_vs_controls_DOWN	NA	816	838
bsdb:46/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	838
bsdb:47/1/1_Obesity:low_vs_high-dietary-fiber_UP	NA	1263
bsdb:47/2/2_Obesity:low_vs_hight-moderate-to-vigrous-physical-activity_DOWN	NA	189330	28050	577309
bsdb:48/1/1_Obesity:obese-adolescent_vs_control-adolescent_UP	NA	838
bsdb:48/1/2_Obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	816	239759	216851	459786
bsdb:48/2/1_Obesity:high-BMI-zscore_vs_low-BMI-zscores_UP	NA	838
bsdb:48/2/2_Obesity:high-BMI-zscore_vs_low-BMI-zscores_DOWN	NA	816	239759
bsdb:48/3/1_Obesity:high-triglycerides_vs_low-triglycerides_UP	NA	838
bsdb:48/3/2_Obesity:high-triglycerides_vs_low-triglycerides_DOWN	NA	816
bsdb:48/4/1_Obesity:high-total-cholesterol_vs_low-total-cholesterol_DOWN	NA	816
bsdb:48/5/1_Obesity:high-HDL-C_vs_low-HDL-C_UP	NA	816
bsdb:48/6/1_Obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_UP	NA	838
bsdb:48/6/2_Obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_DOWN	NA	816	459786
bsdb:49/1/1_Obesity:Obesity-group_vs_controls_UP	NA	43996	117563	86331	1257	838	123375
bsdb:49/1/2_Obesity:Obesity-group_vs_controls_DOWN	NA	724	2717	1016	47670	1716	1279	40323
bsdb:50/1/1_Colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_UP	NA	836	561	620	1350	1301	1257
bsdb:50/1/2_Colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_DOWN	NA	816	841	239759	1730	577310
bsdb:51/1/1_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_UP	NA	1578	838	150022	48736	1380	404402	1283313	1716	135858	1573535	543311	286	1378	1257	836	46255	117563	1654
bsdb:51/1/2_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	32067	196082	1678	33882	1847725	1573534	40544	28050	1506577	570
bsdb:51/2/1_Colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_UP	NA	46123	1380	581	838	123375
bsdb:51/2/2_Colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	574697	1263	1485	33042	150022	437755	459786	872	244127
bsdb:52/1/1_Substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_UP	NA	838	265	1485	33057
bsdb:52/1/2_Substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_DOWN	NA	35832	189330	375288	1301	207244	906	1407607	239759	204475	816	1263
bsdb:52/2/1_Substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_UP	NA	33057	265	838
bsdb:52/2/2_Substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_DOWN	NA	207244	375288	204475	35832	1301	906	1407607
bsdb:55/1/1_Stimulus-or-stress-design:grid-floor-induced-stress_vs_control_UP	NA	283168	239759
bsdb:56/1/1_Type-II-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_UP	NA	283	561	570	583	620
bsdb:56/2/1_Gestational-diabetes:Baby-meconium-with-GDM-mothers_vs_Healthy-baby-meconium_DOWN	NA	507	106589	283	80865	40323
bsdb:56/3/1_Type-II-diabetes-mellitus:Baby-meconium-with-DM-mothers_vs_Healthy-baby-meconium_UP	NA	904	267408	1380	1678	574697	135858	102106	33042	39948	189330	156973	1730	1378	2053	61170	57493	33882	88138	459786	375288	162291	836	838	841	125216	1263	191303
bsdb:57/1/1_Irritable-bowel-syndrome:irritable-bowel-syndrome_vs_control_UP	NA	838	1485	79206	1257	507	32008	482
bsdb:57/1/2_Irritable-bowel-syndrome:irritable-bowel-syndrome_vs_control_DOWN	NA	1716	1743	1301	13687	286
bsdb:57/2/1_Irritable-bowel-syndrome:overweight-irritable-bowel-syndrome_vs_control_UP	NA	1716	1678	1380	133925	1386	162291	1578	113286	265975	177971	39948	906	970	92793	80865	194	286	157	838	1279
bsdb:57/2/2_Irritable-bowel-syndrome:overweight-irritable-bowel-syndrome_vs_control_DOWN	NA	396388	59732	109244	670486	1378	1301	482	724	838	1279
bsdb:58/1/1_High-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_UP	NA	1357	117563	1350
bsdb:58/1/2_High-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_DOWN	NA	40544	375288	816	283
bsdb:58/2/1_High-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_UP	NA	1301	561
bsdb:58/2/2_High-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_DOWN	NA	816
bsdb:60/1/1_Type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_UP	NA	458839	111142	504481	255204
bsdb:60/1/2_Type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_DOWN	NA	92793	338	1847
bsdb:60/2/1_Type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_UP	NA	504481
bsdb:60/2/2_Type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_DOWN	NA	816
bsdb:61/1/1_Obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-1-month_DOWN	NA	816	838
bsdb:61/3/1_Obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-1-month_DOWN	NA	816	838
bsdb:62/1/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	1578	1301	2152
bsdb:62/2/1_Parkinson's-disease:Mild-Cognitive-Impairment-PD_vs_Cognitively-Unimpaired-PD-(PD-NC)_UP	NA	1301	1578
bsdb:62/2/2_Parkinson's-disease:Mild-Cognitive-Impairment-PD_vs_Cognitively-Unimpaired-PD-(PD-NC)_DOWN	NA	2152
bsdb:63/2/1_Cesarean-section:C-section-delivery_vs_vaginal-delivery-after-3-months-of-delivery_DOWN	NA	1578
bsdb:64/1/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	416916	32067
bsdb:64/4/1_Periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_UP	NA	32067
bsdb:64/4/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_DOWN	NA	482	29465
bsdb:65/1/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	416916	482	1378	538	1654	1016	848	29465	1301	970
bsdb:65/1/2_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	1730	44259	836	195950	157
bsdb:66/1/1_Neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_UP	NA	106589
bsdb:66/2/2_Neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	1301
bsdb:67/2/1_Autism:autistic_vs_neurotypical_UP	NA	1578	102106	1716	189330
bsdb:67/2/2_Autism:autistic_vs_neurotypical_DOWN	NA	239759	39948	375288	29465	35832
bsdb:67/3/1_Autism:constipated-autistic_vs_non-constipated-autistic_UP	NA	561	620	1485
bsdb:67/4/1_Autism:constipated-neurotypical_vs_non-constipated-neurotypical_DOWN	NA	204475
bsdb:68/1/1_Obesity:obese_vs_normal-weight_UP	NA	35832	572511	1485	33042	140625	1578	1263	1301
bsdb:68/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	1485	33042	51514	189330	119852	375288
bsdb:68/2/1_Obesity:overweight_vs_normal-weight_UP	NA	816	1578	1301	1485	572511	140625	1263	35832
bsdb:68/2/2_Obesity:overweight_vs_normal-weight_DOWN	NA	51514	119852	375288
bsdb:68/3/1_Obesity:obese-men_vs_normal-weight-men_UP	NA	1578	1301	572511
bsdb:68/3/2_Obesity:obese-men_vs_normal-weight-men_DOWN	NA	1716	51514	1263
bsdb:68/4/1_Obesity:overweight-men_vs_normal-weight-men_UP	NA	816	1578	1301	572511	33042	140625
bsdb:68/4/2_Obesity:overweight-men_vs_normal-weight-men_DOWN	NA	1716	51514	150022	906	1263
bsdb:68/5/1_Obesity:obese-women_vs_normal-weight-women_UP	NA	1301	140625	1263
bsdb:68/5/2_Obesity:obese-women_vs_normal-weight-women_DOWN	NA	51514
bsdb:68/6/1_Obesity:overweight-women_vs_normal-weight-women_UP	NA	1301	1263	140625
bsdb:69/1/1_Sex-design:female_vs_male_UP	NA	1263
bsdb:69/2/1_Obesity:female-obese_vs_female-normal-weight_DOWN	NA	33024
bsdb:69/3/1_Obesity:male-obese_vs_male-normal-weight_UP	NA	574697	848
bsdb:69/4/1_Obesity:obese_vs_normal-weight_UP	NA	848
bsdb:70/1/1_Obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	39948	816	838
bsdb:70/1/2_Obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	207244	40544	816
bsdb:70/2/2_Obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_DOWN	NA	283168
bsdb:71/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1243	909928	2737	830
bsdb:71/2/1_Premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_UP	NA	1386	1279	1350	2737	1578	1243	1485	29465	909928	1678	547	544	551	570	160674	53335	29487	195950
bsdb:71/2/2_Premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_DOWN	NA	223927
bsdb:72/1/2_Autism:autism_vs_typically-developing-controls_DOWN	NA	1301	29465	561	1654	543311	118747	162289
bsdb:73/1/1_Obesity:obese_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	816
bsdb:73/2/1_Obesity:obese-+-metabolic-syndrome_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/2/2_Obesity:obese-+-metabolic-syndrome_vs_normal-weight_DOWN	NA	816
bsdb:74/1/2_Obesity:obese_vs_non-obese_DOWN	NA	239759	195950
bsdb:74/2/2_Obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	239759
bsdb:74/3/1_Obesity:high-BMI_vs_low-BMI_UP	NA	55079	1678	662	629
bsdb:74/3/2_Obesity:high-BMI_vs_low-BMI_DOWN	NA	239759	195950
bsdb:74/4/1_Obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_UP	NA	55079
bsdb:74/4/2_Obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_DOWN	NA	239759	195950
bsdb:75/1/1_Smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_UP	NA	1016	1257	848	12916	724	482
bsdb:75/1/2_Smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_DOWN	NA	906	29465	52228	1301
bsdb:75/2/1_Smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_UP	NA	1016	848	482	416916
bsdb:75/2/2_Smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_DOWN	NA	1654	84111	906	29465	34104
bsdb:75/3/1_Smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_UP	NA	1654	1243	469	407217	620	349
bsdb:75/3/2_Smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_DOWN	NA	84111	189330	1730	46123	174708	109326	33042	150022	1378	84036	52784
bsdb:75/4/1_Smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_UP	NA	237	1647	1378	620	40544
bsdb:75/4/2_Smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_DOWN	NA	84111	836	46123	52784	109326	189330	1730	841	84036	194	724	40323
bsdb:76/1/1_Type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_UP	NA	572511	904
bsdb:76/1/2_Type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_DOWN	NA	39948	724	1392389
bsdb:77/1/2_Bipolar-disorder:atypical-antipsychotic-users_vs_non-users_DOWN	NA	239934
bsdb:78/1/1_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_UP	NA	1350	1301	2740	1375	227979	66831	1485	1716	872	117563	32207	583	100883	1357	191303	2316
bsdb:78/1/2_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	1263	841	33042	1573535	1279	375288	28050	244127	724	283168
bsdb:79/1/1_Obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	33042	189330	1263
bsdb:79/2/1_Obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	100883	1350	61170	1578	265975	1263
bsdb:80/1/1_Type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_UP	NA	816
bsdb:80/1/2_Type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_DOWN	NA	838	904	158846
bsdb:83/1/1_Obesity:before-surgery_vs_after-surgery_UP	NA	207244	33042	216851	209	5782	40637
bsdb:83/1/2_Obesity:before-surgery_vs_after-surgery_DOWN	NA	544	547	590	29465	5140
bsdb:85/1/1_Cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/2/1_Cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816
bsdb:85/3/1_Cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/4/1_Cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816	102106
bsdb:86/1/1_Cesarean-section:c-section_vs_vaginal-delivery-at-day-3_UP	NA	1279	1578
bsdb:86/3/1_Cesarean-section:c-section_vs_vaginal-delivery-at-day-28_DOWN	NA	816
bsdb:86/4/1_Cesarean-section:c-section_vs_vaginal-delivery-at-day-150_DOWN	NA	816
bsdb:86/7/1_Cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_UP	NA	239934	207244	1485	39948	547	1350	946234	1378	724	1578	1743	32207	1279	1301
bsdb:86/7/2_Cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_DOWN	NA	375288	816	239759
bsdb:87/1/1_Type-I-diabetes-mellitus:Type-I-Diabetics_vs_maturity-onset-diabetes-of-the-young-2-(MODY2)-and-healthy-Controls_UP	NA	572511	816	29465	1263	1301	547	40544
bsdb:87/2/1_Type-I-diabetes-mellitus:Type-I-Diabetics-and-maturity-onset-diabetes-of-the-young-2-(MODY2)_vs_healthy-Controls_DOWN	NA	28050	841	207244	216851
bsdb:88/1/1_Schizophrenia:schizophrenia_vs_non-psychiatric-controls_UP	NA	165779	906	572511
bsdb:88/1/2_Schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	724	40544	1485
bsdb:89/1/1_Crohn's-disease:CD-patients_vs_Healthy-controls_UP	NA	1654	1678
bsdb:89/1/2_Crohn's-disease:CD-patients_vs_Healthy-controls_DOWN	NA	698776	1730	61170	375288	841	1017280	292632
bsdb:90/1/1_Cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_UP	NA	209
bsdb:90/1/2_Cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_DOWN	NA	469	70774	1301	13687	1716	42255	165695	129337	482	165779	407	29465	1269	1357	357	212791	29580	80865
bsdb:90/2/1_Cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_UP	NA	29465	1350
bsdb:90/2/2_Cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_DOWN	NA	286	400634	1716	1301	106589	32067	1654	848	13687	42255	2745	157	724	41275	2717	165695
bsdb:91/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1386	1298	1730	216851	40323
bsdb:91/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1743	283	286
bsdb:92/2/1_Non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_healthy-controls_UP	NA	838
bsdb:92/3/1_Non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_obese-without-non-alcoholic-fatty-liver-disease_UP	NA	838
bsdb:93/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1279
bsdb:93/2/1_Cesarean-section:Antimicrobials-use-during-delivery-(yes)_vs_Antimicrobials-use-during-delivery-(no)_UP	NA	1678
bsdb:93/3/1_Cesarean-section:Maternal-consumption-of-probiotics-(YES)_vs_Maternal-consumption-of-probiotics-(NO)_UP	NA	1578
bsdb:93/4/1_Cesarean-section:Furry-pets-at-home-(YES)_vs_Furry-pets-at-home-(NO)_UP	NA	216851
bsdb:93/4/2_Cesarean-section:Furry-pets-at-home-(YES)_vs_Furry-pets-at-home-(NO)_DOWN	NA	1279
bsdb:95/1/1_Obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_UP	NA	189330	841
bsdb:95/1/2_Obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_DOWN	NA	375288
bsdb:96/1/1_Obesity:obese_vs_controls_UP	NA	239759	165779	33042	848	543311
bsdb:96/1/2_Obesity:obese_vs_controls_DOWN	NA	816	872	216851	150022	1164882	133925	292632
bsdb:97/2/1_Obesity:Roux-en-Y-gastric-bypass-(RYGB)_vs_healthy-controls_UP	NA	1678	906
bsdb:97/3/1_Obesity:obese-patients-three-months-after-Sleeve-gastrectomy-SG3_vs_obese-patients-prior-to-Sleeve-gastrectomy-SG0_DOWN	NA	239759	1301
bsdb:97/4/1_Obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_UP	NA	216851
bsdb:97/4/2_Obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_DOWN	NA	1301
bsdb:98/1/1_Chronic-kidney-disease:CKD_vs_controls_UP	NA	469	1386	81	445	68	1664383	286	504481	613	629
bsdb:98/1/2_Chronic-kidney-disease:CKD_vs_controls_DOWN	NA	1705353	911113	1716	1210119	265	13687	40323	1506577
bsdb:99/1/2_Obesity:obese_vs_controls_DOWN	NA	816	239759
bsdb:100/1/1_Obesity:High-BMI_vs_low-BMI_UP	NA	613	838
bsdb:100/2/1_Obesity:Abdominal-obesity_vs_non-abdominal-obesity_UP	NA	613	838
bsdb:100/2/2_Obesity:Abdominal-obesity_vs_non-abdominal-obesity_DOWN	NA	119852
bsdb:101/1/1_Obesity:obese_vs_lean-controls_UP	NA	1578
bsdb:102/1/1_Type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_UP	NA	838	1263
bsdb:102/1/2_Type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_DOWN	NA	572511	239759
bsdb:103/1/1_Unipolar-depression:depressed-female_vs_Healthy-Controls_UP	NA	572511	1654	1678	553372	1380	84111	644652	133925	1730	207244	841	216851	872
bsdb:103/1/2_Unipolar-depression:depressed-female_vs_Healthy-Controls_DOWN	NA	404402	40544	638847
bsdb:103/2/1_Unipolar-depression:depressed-male_vs_Healthy-Controls_UP	NA	1380	816	29465
bsdb:103/2/2_Unipolar-depression:depressed-male_vs_Healthy-Controls_DOWN	NA	644652	109326	638847
bsdb:104/1/1_Unipolar-depression:major-depressive-disorder-(visit-1)_vs_healthy-controls_UP	NA	838	570	1301
bsdb:104/2/1_Unipolar-depression:major-depressive-disorder-(visit-2)_vs_healthy-controls_UP	NA	838	1301
bsdb:105/1/1_Bipolar-disorder:Bipolar_vs_Healthy-controls_DOWN	NA	216851
bsdb:106/1/1_Bipolar-disorder:bipolar-disorder-patients_vs_healthy-controls_UP	NA	946234
bsdb:106/2/1_Bipolar-disorder:bipolar-disorder-patients_vs_unaffected-relatives_UP	NA	946234
bsdb:107/1/2_Anorexia-nervosa:Anorexia-patients-at-T1_vs_Healthy-comparison-group-(HCG)_DOWN	NA	207244	216851
bsdb:107/2/1_Anorexia-nervosa:Anorexia-patients-at-T2_vs_Healthy-comparison-group-(HCG)_UP	NA	375288
bsdb:108/1/1_Anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	1301
bsdb:109/1/1_Anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_UP	NA	207244	244127	1678	1485
bsdb:109/1/2_Anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_DOWN	NA	204475	841
bsdb:109/2/1_Anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_UP	NA	207244	1678	1578	1357	1017280	1263	44748	1485
bsdb:109/2/2_Anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_DOWN	NA	816	1485
bsdb:110/1/1_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1678	1578
bsdb:111/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_UP	NA	469	990721	100883	1573534	1473205	40323	1505652
bsdb:111/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	39948	1506553	216851	40544	904	1508657	1506577
bsdb:112/1/1_Attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_UP	NA	482	816
bsdb:112/1/2_Attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_DOWN	NA	838	375288
bsdb:113/1/1_Unipolar-depression:MDD_vs_controls_DOWN	NA	1678
bsdb:114/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	846	543311	118747	286	1257	1378
bsdb:114/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	216851	33042	572511	189330
bsdb:115/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	1485	1678	459786	1301	970	906	904	838
bsdb:115/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	816	283168	195950
bsdb:115/2/1_Bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	816	283168	195950
bsdb:116/1/1_Type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_UP	NA	1485	816	29465
bsdb:116/1/2_Type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	838	1678	1578
bsdb:117/1/1_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	1578	32207
bsdb:117/1/2_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	32067	196082
bsdb:117/2/1_Pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	1578	32207
bsdb:117/2/2_Pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	724	32067	482
bsdb:118/1/1_Cesarean-section:cesarean-born_vs_vaginal-born-children_UP	NA	1578
bsdb:118/1/2_Cesarean-section:cesarean-born_vs_vaginal-born-children_DOWN	NA	1678
bsdb:118/2/1_Cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_UP	NA	29465	1350
bsdb:118/2/2_Cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_DOWN	NA	1506577	838	216851
bsdb:119/1/1_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_UP	NA	1678
bsdb:119/2/1_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_UP	NA	838
bsdb:119/2/2_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_DOWN	NA	1678
bsdb:119/3/1_Type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_UP	NA	1678
bsdb:119/3/2_Type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_DOWN	NA	838
bsdb:120/1/1_Physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_UP	NA	838	1485	1350	816
bsdb:120/1/2_Physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	816	1678	1578
bsdb:120/2/1_Physical-activity:Ad-libitum-group_vs_exercise-group_UP	NA	816	838	1350	1485
bsdb:120/2/2_Physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	1678	1578
bsdb:121/1/1_Gingivitis:gingivitis_vs_healthy-controls_UP	NA	836	195950	157
bsdb:121/1/2_Gingivitis:gingivitis_vs_healthy-controls_DOWN	NA	1016
bsdb:122/1/1_Breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	237	407
bsdb:122/1/2_Breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	13687	914	374
bsdb:123/1/1_Diet:high-fat-diet_vs_low-fat-diet_UP	NA	1357	117563	1486725	109326	1485	33042	1730	216851	946234	119852	100175	1017280	44748	1506577	1505663	61170	32207	447020	102106
bsdb:123/1/2_Diet:high-fat-diet_vs_low-fat-diet_DOWN	NA	544	397864	816	588605
bsdb:124/1/2_Diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1678	561	1357
bsdb:124/2/1_Diet:body-builders-(high-protein)_vs_control_UP	NA	40544	216851	1485	724	1432051
bsdb:124/2/2_Diet:body-builders-(high-protein)_vs_control_DOWN	NA	1678	577310	1243
bsdb:124/3/1_Diet:distance-runners-(high-carb)_vs_control_UP	NA	40544
bsdb:124/3/2_Diet:distance-runners-(high-carb)_vs_control_DOWN	NA	572511	547	46255	1243
bsdb:125/1/1_Squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_UP	NA	1257	848	1283313	1016
bsdb:125/1/2_Squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_DOWN	NA	32207	724
bsdb:126/1/1_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_UP	NA	724	1386
bsdb:126/1/2_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/2/1_Oral-squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_UP	NA	724	1386
bsdb:126/2/2_Oral-squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/3/1_Oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_UP	NA	724	1301
bsdb:126/3/2_Oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_DOWN	NA	1386
bsdb:127/1/1_Alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	1485	61170	40544
bsdb:127/1/2_Alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	216851
bsdb:127/2/1_Alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	904	118747	1485	2383	561	61170	570	158846	581	32207	40544
bsdb:127/2/2_Alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	447020	102106	216851	52225	283168	265975	838	1279	674963
bsdb:128/1/1_Gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_UP	NA	1283313	43996	39948	848	543311	1578	437755	2740	1257	838	84108	1301
bsdb:128/1/2_Gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_DOWN	NA	469	57739	378210	235572
bsdb:128/2/1_Gastric-cancer:gastric-cancer_vs_atrophic-gastric_UP	NA	1301	1257	1378	848	543311	1578	1730	1283313	838	39948	84108	2740	43996	437755
bsdb:128/2/2_Gastric-cancer:gastric-cancer_vs_atrophic-gastric_DOWN	NA	57739	235572
bsdb:128/3/1_Gastric-cancer:gastric-cancer_vs_superficial-gastric_UP	NA	1283313	43996	39948	1730	848	1378	1578	437755	543311	2740	1257	838	84108	1301
bsdb:128/3/2_Gastric-cancer:gastric-cancer_vs_superficial-gastric_DOWN	NA	47420	469	57739	378210	235572
bsdb:129/1/1_Multiple-sclerosis:Multiple-sclerosis_vs_Healthy-controls_UP	NA	572511	189330	237	13159	84567	286
bsdb:129/1/2_Multiple-sclerosis:Multiple-sclerosis_vs_Healthy-controls_DOWN	NA	447020	572511	102106	100883	724	1578	2093	375288
bsdb:130/1/1_Diet:high-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/2/1_Diet:intermediate-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/5/1_Diet:>-30-years-participants_vs_20-30-years-participants_UP	NA	1578
bsdb:130/6/2_Diet:BMI->25_vs_BMI-<-20_DOWN	NA	1678
bsdb:130/7/1_Diet:BMI-20-25_vs_BMI-<20_DOWN	NA	1678
bsdb:131/1/1_Diet:Time-7-days_vs_Time-0-days-controls_DOWN	NA	119852
bsdb:131/2/2_Diet:Time-7-days_vs_Time-0-days-Cara-Cara_DOWN	NA	283168
bsdb:131/4/1_Diet:Cara-Cara_vs_controls-at-time-7_UP	NA	375288	189330	244127	574697
bsdb:131/5/1_Diet:Bahia_vs_controls-at-time-7_UP	NA	447020	1350	1485	244127
bsdb:132/1/1_Diet:Meat_vs_mushroom_UP	NA	189330
bsdb:132/1/2_Diet:Meat_vs_mushroom_DOWN	NA	816	375288	33042	207244	40544
bsdb:134/1/1_Diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	872
bsdb:134/2/1_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	1485	872
bsdb:134/2/2_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	239759
bsdb:135/1/1_Diet:High-animal-protein_vs_low-animal-protein_UP	NA	816
bsdb:136/1/2_Diet:Low-vegetable,-fruit,-grains,_vs_high-vegetable,-fruit,-grain_DOWN	NA	1485	1730	459786
bsdb:136/2/1_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	84111	1357	1301	1350	1730	102106	1485	1678	572511
bsdb:136/2/2_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	872	39948	216851	1263	84108	29465
bsdb:137/1/1_Colorectal-cancer:CRC_vs_controls_UP	NA	642	848
bsdb:137/1/2_Colorectal-cancer:CRC_vs_controls_DOWN	NA	816	35832	544	413496	189330	1730	841
bsdb:138/1/1_Lung-cancer:lung-cancer_vs_controls_UP	NA	1654	1380	1350	1505663	1573535	1392389	69965	160674
bsdb:138/1/2_Lung-cancer:lung-cancer_vs_controls_DOWN	NA	447020	226	1678	102106	1348911	189330	28050	175304	437755	162289	1257	46205	1508657	40544
bsdb:139/1/2_Head-and-neck-squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	1716	32257
bsdb:139/2/1_Squamous-cell-carcinoma:Larynx-cancer-cases_vs_controls_DOWN	NA	46123	1016	1716	32257	482
bsdb:139/3/1_Squamous-cell-carcinoma:Pharynx-cancer-cases_vs_controls_DOWN	NA	1716	32257
bsdb:139/4/1_Squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_UP	NA	1654
bsdb:140/1/1_Multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	2172	239934	84593
bsdb:140/1/2_Multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	574697
bsdb:140/2/1_Multiple-sclerosis:multiple-sclerosis-patients_vs_controls_UP	NA	84593	2172	239934
bsdb:140/2/2_Multiple-sclerosis:multiple-sclerosis-patients_vs_controls_DOWN	NA	574697
bsdb:140/3/1_Multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934	2735
bsdb:140/3/2_Multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	574697	838	40544
bsdb:140/4/1_Multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934	2172	2735
bsdb:140/4/2_Multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	574697	838	40544
bsdb:140/5/1_Multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_UP	NA	838	40544
bsdb:140/5/2_Multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_DOWN	NA	1266
bsdb:140/6/1_Multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_UP	NA	838
bsdb:140/6/2_Multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_DOWN	NA	1266
bsdb:141/1/1_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_UP	NA	165779	39948	162289	543311	43996	838	1301
bsdb:141/1/2_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_DOWN	NA	1578
bsdb:142/1/1_Oral-squamous-cell-carcinoma:HNSCC_vs_Controls_UP	NA	1578	543311	1257	1279	1301	195950	29465
bsdb:142/1/2_Oral-squamous-cell-carcinoma:HNSCC_vs_Controls_DOWN	NA	416916	47670	724	482	32067
bsdb:142/2/1_Oral-squamous-cell-carcinoma:HPV-+_vs_HPV--_UP	NA	1578	1013
bsdb:142/2/2_Oral-squamous-cell-carcinoma:HPV-+_vs_HPV--_DOWN	NA	538	482	32067
bsdb:142/3/1_Oral-squamous-cell-carcinoma:chemotherapy-radiation-and-surgery_vs_surgery_UP	NA	1578
bsdb:142/3/2_Oral-squamous-cell-carcinoma:chemotherapy-radiation-and-surgery_vs_surgery_DOWN	NA	724	416916	32067
bsdb:144/1/1_Air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_UP	NA	32207	265975	482	1654
bsdb:144/1/2_Air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_DOWN	NA	848	475	1257	836	838	29465
bsdb:144/2/2_Air-pollution:heavily-polluted-region-(C)_vs_lightly-poluuted-region-(A)_DOWN	NA	194	1016	848	475	1257	836	838	29465
bsdb:144/3/2_Air-pollution:heavily-polluted-region-(C)_vs_moderately-poluuted-region-(B)_DOWN	NA	32207	848	265975	1654	194	482
bsdb:146/1/1_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	2093	157	194	538	82202	1283313	848	970	39948	1257	44259	2740	43996	543311	1016
bsdb:146/1/2_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	906	1213720	117563	47670	29465	1301	196081	32207	1654
bsdb:147/1/1_Squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_UP	NA	848	838	543311	1257	39948	43996	970	157	32008
bsdb:147/1/2_Squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_DOWN	NA	1301	32207
bsdb:147/2/1_Squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_UP	NA	29465	32067	1654	32207	117563	906	265975	1380	437755
bsdb:147/2/2_Squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_DOWN	NA	848	838	543311	1257	836	39948	2093	44259	43996	538	157	416916
bsdb:148/1/1_Polycystic-ovary-syndrome:NIR-PCOS---NIR(Non-Insulin-Resistance)_vs_HC---Healthy-Controls_UP	NA	816	28050
bsdb:148/1/2_Polycystic-ovary-syndrome:NIR-PCOS---NIR(Non-Insulin-Resistance)_vs_HC---Healthy-Controls_DOWN	NA	838
bsdb:148/2/1_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_HC---Healthy-Controls_UP	NA	816	28050
bsdb:148/2/2_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_HC---Healthy-Controls_DOWN	NA	838
bsdb:148/3/1_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_NIR-PCOS---NIR(Non-Insulin-Resistance)_UP	NA	816
bsdb:148/3/2_Polycystic-ovary-syndrome:IR-PCOS-IR-(Insulin-Resistance)_vs_NIR-PCOS---NIR(Non-Insulin-Resistance)_DOWN	NA	216851
bsdb:149/1/1_Obesity:Obese-children_vs_Normal-weight-children_UP	NA	158846
bsdb:149/1/2_Obesity:Obese-children_vs_Normal-weight-children_DOWN	NA	207244	61170	459786
bsdb:150/1/1_Head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_UP	NA	286	416916	216851	1508657	47670	909656	816
bsdb:150/1/2_Head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_DOWN	NA	713	109326	59735	194	1716	1730	848	724	1506553	32067	475	482	543311	1257	836	838	841	32207	970	157	29465
bsdb:150/2/1_Head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	547	416916	286
bsdb:150/2/2_Head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_DOWN	NA	848	838	44259	713	209	1730	841	109326	872	43994
bsdb:152/1/1_Cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	189330	581	583	1263	22	83770
bsdb:152/1/2_Cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	2745	33024
bsdb:152/2/1_Cervical-cancer:cervical-cancer-patients_vs_healthy-controls_UP	NA	375288	841
bsdb:152/2/2_Cervical-cancer:cervical-cancer-patients_vs_healthy-controls_DOWN	NA	33024
bsdb:153/1/1_Prostate-cancer:prostate-cancer_vs_non-prostate-cancer_UP	NA	2747	129337	1357	1301
bsdb:153/1/2_Prostate-cancer:prostate-cancer_vs_non-prostate-cancer_DOWN	NA	114627	413496	1350	44249
bsdb:154/1/1_Colorectal-cancer:colorectal-cancer_vs_healthy-controls_UP	NA	46913	44249	59732
bsdb:154/1/2_Colorectal-cancer:colorectal-cancer_vs_healthy-controls_DOWN	NA	838	1730	570	32067	33024	86331	613
bsdb:155/1/1_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	29465	970
bsdb:155/1/2_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	1283313	265975	123375	482	724
bsdb:155/2/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	59735
bsdb:155/2/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	838
bsdb:156/1/1_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	838	561	620	570	1578	1301	239759	29465	1678	990721	375288
bsdb:156/1/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	216851	841	28050	1506553
bsdb:156/2/1_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	1729679	838	561	620	570	1301	1578	239759	1678	29465
bsdb:156/2/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	841	28050	1506553
bsdb:157/1/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_UP	NA	44259	1578	836	838	1301	46123
bsdb:157/1/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_DOWN	NA	416916	1380	118747	194	43996	1716	44259	848	724	963	47670	32067	482	265975	2740	32207	29465	2717
bsdb:157/2/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Healthy-controls_UP	NA	816	1016	308865	836	838	1301	830
bsdb:157/2/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Healthy-controls_DOWN	NA	2147	1654	416916	1380	118747	830	194	2717	43996	1716	39948	44259	724	47670	906	482	265975	2740	1257	32207	970	157	29465	32067
bsdb:158/1/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	816	29465	848	33024
bsdb:158/1/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	579	216851	547	39948	561	620
bsdb:158/2/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	848	570	816
bsdb:158/2/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	39948	547	561	216851	620
bsdb:159/1/1_Gingival-disease:1-month-after-the-placement-of-the-brackets_vs_before_UP	NA	713	1016
bsdb:159/2/1_Gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:159/2/2_Gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	117563
bsdb:160/1/1_Head-and-neck-carcinoma:OCC-&-OPC_vs_High-risk-individuals_DOWN	NA	346096	1716	836	1654	713	1016	848	416916	47670
bsdb:160/2/1_Head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_UP	NA	265975
bsdb:160/2/2_Head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_DOWN	NA	32207	724	1716	346096	836	1016
bsdb:161/1/1_Lung-cancer:NSCLC_vs_Healthy-controls_UP	NA	1301	47670
bsdb:161/1/2_Lung-cancer:NSCLC_vs_Healthy-controls_DOWN	NA	838
bsdb:163/1/1_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	1654	1678	872	437755	55506	970	157
bsdb:163/1/2_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	43996	724	482	838	1301	29465
bsdb:163/2/1_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	146	29465
bsdb:163/2/2_Squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	1213720
bsdb:164/1/1_Gastric-cancer:gastric-cancer_vs_controls_UP	NA	838	1301	29465	1654	32067
bsdb:164/1/2_Gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	482	848	724	836	1301
bsdb:165/1/1_Chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_UP	NA	1283313	1485	872	407	577309
bsdb:165/1/2_Chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_DOWN	NA	239934	174708	580024	1730	209	1578	1357	1243	248038	133925	265975	577310	1427376	638847	32207	2753
bsdb:166/1/1_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	816	84111	1505663	561	946234	375288	1508657	1769710	620	46255
bsdb:166/1/2_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1506577	102106	580596	1501226	1263	841	33042	292632	28050	2747	39948
bsdb:167/1/1_Squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	82202
bsdb:167/3/1_Squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_UP	NA	1730
bsdb:168/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_UP	NA	283	47670	482
bsdb:168/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_DOWN	NA	194	1331051	543311	1481960	196081
bsdb:168/2/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_UP	NA	2093	482
bsdb:168/2/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_DOWN	NA	43996	838
bsdb:168/3/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_UP	NA	59735	118747	82202	836
bsdb:168/3/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_DOWN	NA	1654	194195	113286	196081
bsdb:169/1/1_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	47670	50729
bsdb:169/1/2_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	1213720
bsdb:169/3/1_Gastric-cancer:yellow-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	47670	482	1257
bsdb:169/4/1_Gastric-cancer:yellow-thin-coating-GC-patient_vs_other-coatings_DOWN	NA	5543
bsdb:170/1/1_Lung-cancer:cancerous-site_vs_controls_UP	NA	1301
bsdb:170/1/2_Lung-cancer:cancerous-site_vs_controls_DOWN	NA	1279
bsdb:170/2/1_Lung-cancer:paired-contralateral-non-cancerous-site-in-lung-cancer-patients_vs_controls_UP	NA	1016	237	724	32067	482	970	1301
bsdb:170/2/2_Lung-cancer:paired-contralateral-non-cancerous-site-in-lung-cancer-patients_vs_controls_DOWN	NA	469
bsdb:170/3/1_Sampling-site:cancerous-site-(T)_vs_paired-contralateral-non-cancerous-site-(TN)_UP	NA	39948
bsdb:170/4/1_Lung-cancer:cancerous-site-with-no-antibiotics_vs_control-group-with-no-antibiotics_UP	NA	1016
bsdb:170/4/2_Lung-cancer:cancerous-site-with-no-antibiotics_vs_control-group-with-no-antibiotics_DOWN	NA	265	1279	1004300
bsdb:170/5/1_Lung-cancer:contralateral-non-cancerous-site-with-no-antibiotics-(TNo)_vs_control-group-with-no-antibiotics-(No)_UP	NA	482	1279
bsdb:170/5/2_Lung-cancer:contralateral-non-cancerous-site-with-no-antibiotics-(TNo)_vs_control-group-with-no-antibiotics-(No)_DOWN	NA	33042	469	816	1004300
bsdb:170/6/1_Sampling-site:Cancerous-site-with-no-antibiotics-(To)_vs_contralateral-non-cancerous-site-with-no-antibiotics-(TNo)_UP	NA	33024
bsdb:171/1/1_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_UP	NA	1716	848	482	29465
bsdb:171/1/2_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_DOWN	NA	836	838	32207
bsdb:171/2/1_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_UP	NA	1716	32067	482	838
bsdb:171/2/2_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_DOWN	NA	1301
bsdb:171/3/1_Esophageal-cancer:esophageal-cancer-patients_vs_controls_UP	NA	1716
bsdb:171/3/2_Esophageal-cancer:esophageal-cancer-patients_vs_controls_DOWN	NA	1654	1301	482
bsdb:171/4/1_Colorectal-cancer:colorectal-cancer-patients_vs_controls_UP	NA	1716	482
bsdb:171/4/2_Colorectal-cancer:colorectal-cancer-patients_vs_controls_DOWN	NA	838	1301
bsdb:171/5/1_Gastric-cancer:gastric-cancer-patients_vs_controls_UP	NA	482	1301
bsdb:171/5/2_Gastric-cancer:gastric-cancer-patients_vs_controls_DOWN	NA	838	32207	1301
bsdb:172/1/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	85413	80865	88	86331	32207
bsdb:172/1/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735	1016	848	836
bsdb:172/2/1_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	86331	970	29465
bsdb:172/2/2_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	59735	1301
bsdb:172/3/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	85413	80865	47670	88	286	32207
bsdb:172/3/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735
bsdb:172/4/1_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	86331	838	29465
bsdb:172/4/2_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	59735	400634
bsdb:173/1/1_Pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_UP	NA	904	416916	194	135858	82202	413496	547	52228	570	1578	32067	200903	838	970	29465
bsdb:173/1/2_Pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_DOWN	NA	239934	239759	207244	244127	1678	35832	572511	41275	580596	1485	33042	189330	84111	946234	204475	158846	906	86331	651554	577310	583	379	44748
bsdb:173/2/1_Pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_pancreatic-head-cancer-without-obstruction_UP	NA	283	117563	140625	32067	115543	46205	1200657	1301
bsdb:173/2/2_Pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_pancreatic-head-cancer-without-obstruction_DOWN	NA	118966	561	620
bsdb:174/1/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	970	838	1164882	1301	1257	13687	469	1386
bsdb:174/1/2_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_DOWN	NA	613	209	1543704	1357
bsdb:174/2/1_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_UP	NA	613	209	263960	69965	111142	292480	2093	1578	207599	110932	1860	416916	1301
bsdb:174/2/2_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_DOWN	NA	286
bsdb:174/3/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	469	1386	816	13687	1257	1301	848
bsdb:174/3/2_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_DOWN	NA	209	1578
bsdb:175/1/1_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_UP	NA	1283313
bsdb:175/1/2_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:175/2/1_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	1283313	32067
bsdb:175/3/1_Pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:176/1/1_Leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_UP	NA	1716	162289	150022	1279	1654
bsdb:176/1/2_Leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_DOWN	NA	216851	1263	28050
bsdb:177/1/1_Colorectal-cancer:colon-cancer-patients_vs_control-group_UP	NA	35832	1485	39948	848	2172	119852	1257
bsdb:177/1/2_Colorectal-cancer:colon-cancer-patients_vs_control-group_DOWN	NA	1301
bsdb:177/2/1_Colorectal-cancer:colon-cancer-patients-(tumor-samples)_vs_control-group_UP	NA	2172	1257	970
bsdb:177/3/1_Colorectal-cancer:colon-cancer-patients-(fecal-samples)_vs_control-group_UP	NA	189330	1257
bsdb:177/3/2_Colorectal-cancer:colon-cancer-patients-(fecal-samples)_vs_control-group_DOWN	NA	841
bsdb:178/1/1_Gastric-cancer:gastric-cancer-peritumor-group_vs_normal_UP	NA	2745	22	1350	41275	1663	1763
bsdb:178/1/2_Gastric-cancer:gastric-cancer-peritumor-group_vs_normal_DOWN	NA	106589	445
bsdb:178/2/1_Gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_UP	NA	1350	970	2745	1678	239759	1263	39948	459786	33042	841	906	1279	572511
bsdb:178/2/2_Gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_DOWN	NA	379	158846	22	1763	1578
bsdb:178/3/1_Gastric-cancer:gastric-cancer-tumor-group_vs_normal_UP	NA	92793	1678	572511	33042	39948	1378	204475	117563	70774	1578	149698	407	482	1257	1743	841	42255	1263	22	1301	29465
bsdb:178/3/2_Gastric-cancer:gastric-cancer-tumor-group_vs_normal_DOWN	NA	1716	106589	1654	1279
bsdb:179/1/1_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654	1380	2717
bsdb:179/1/2_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:179/2/1_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654	1380
bsdb:179/2/2_Esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:181/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-control_UP	NA	239934	572511	946234	283168	459786	375288	29465
bsdb:181/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-control_DOWN	NA	838
bsdb:184/1/1_Prostate-cancer:prostate-cancer-patients_vs_controls_UP	NA	816
bsdb:184/1/2_Prostate-cancer:prostate-cancer-patients_vs_controls_DOWN	NA	216851	28050	258514
bsdb:185/1/1_Gastric-cancer:gastric-cancer_vs_controls_UP	NA	561	620	1485	29465
bsdb:185/1/2_Gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	816
bsdb:185/2/1_Gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer-(post-surgery)_UP	NA	570
bsdb:185/2/2_Gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer-(post-surgery)_DOWN	NA	239934	620	1578	39948
bsdb:187/1/1_Medroxyprogesterone-acetate:naive-black-participants-(baseline-visit)_vs_depot-medroxyprogesterone-acetate-vaginal-microbiome-(visit-2)-among-black-participants_UP	NA	838
bsdb:187/2/1_Medroxyprogesterone-acetate:white-naiive-vaginal-microbiome-(baseline)_vs_black-naive-vaginal-microbiome-(baseline-visit-)_UP	NA	150022
bsdb:187/2/2_Medroxyprogesterone-acetate:white-naiive-vaginal-microbiome-(baseline)_vs_black-naive-vaginal-microbiome-(baseline-visit-)_DOWN	NA	1485	177971
bsdb:187/3/1_Medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-2)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-2)_UP	NA	1578
bsdb:187/3/2_Medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-2)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-2)_DOWN	NA	1485	848	1378	838	168808
bsdb:187/4/1_Medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-3)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-3)_UP	NA	150022
bsdb:187/4/2_Medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-3)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-3)_DOWN	NA	1375	906	838
bsdb:188/1/1_Cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	2701
bsdb:189/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	158846	1654
bsdb:189/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	816	574697	375288	553372	239759	1263
bsdb:190/1/1_Environmental-exposure-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk-(<20th-percentile)_UP	NA	1485	1350
bsdb:190/1/2_Environmental-exposure-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk-(<20th-percentile)_DOWN	NA	1578	29465
bsdb:192/1/2_Irritable-bowel-syndrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_DOWN	NA	216851
bsdb:192/2/1_Irritable-bowel-syndrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_UP	NA	253238
bsdb:194/1/1_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	212791	283	1279	165695	407	106589	586	196013	504481	12916	13687	469
bsdb:194/1/2_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	236752	1357
bsdb:195/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_UP	NA	629	44259
bsdb:195/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_DOWN	NA	32067	1016
bsdb:195/2/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_UP	NA	44259	157
bsdb:195/2/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_DOWN	NA	482
bsdb:196/1/1_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_UP	NA	29465	1350	158846	375288
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_DOWN	NA	39948	724	570	28050	577310	841	1508657	1263	1301
bsdb:197/1/1_Asthma:severe-asthma_vs_non-asthma_UP	NA	239759	207244	816	1016	1432051	1730	216851	946234	5277	283168	459786	375288	4753	5533	1501226	841	1263
bsdb:197/1/2_Asthma:severe-asthma_vs_non-asthma_DOWN	NA	5206	237557	583	5615
bsdb:198/1/1_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_UP	NA	482	29465	838
bsdb:198/1/2_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_DOWN	NA	724	469
bsdb:199/1/2_Ovarian-cancer:ovarian-cancer_vs_controls_DOWN	NA	44249	2251
bsdb:200/1/2_Postmenopausal:Post-menopausal-patients_vs_Pre-menopausal-patients_UP	NA	1380	816	572511	194	1485	39948	216851	162290	33983	2740	162289	836	285105	72763	184869	165779	419014	1654	437755
bsdb:200/2/1_Endometrial-cancer:Endometrial-cancer_vs_Benign_DOWN	NA	1578
bsdb:200/2/2_Endometrial-cancer:Endometrial-cancer_vs_Benign_UP	NA	1654	28263	194	150022	848	162290	1578	2740	162289	836	838	184869	165779
bsdb:201/1/1_Leukemia:induction_vs_repeat-therapy_UP	NA	816	216851	459786	375288	1263
bsdb:201/1/2_Leukemia:induction_vs_repeat-therapy_DOWN	NA	1654	84111	1350	1573536	1578	292632	29465
bsdb:202/1/1_Autism:children-with-autism-mental-regression-(AMR)_vs_children-with-autism-non-mental-regression-(ANMR)_UP	NA	1350
bsdb:202/2/1_Autism:children-with-autism-non-mental-regression-(ANMR)_vs_healthy-controls_UP	NA	1678	1350
bsdb:202/3/1_Autism:children-with-autism-mental-regression-(AMR)_vs_healthy-controls_UP	NA	1678	1350
bsdb:204/1/1_Premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-37-getastional-weeks_DOWN	NA	1678
bsdb:207/1/1_Vulvovaginitis:Women-with-BV_vs_Normal-controls_UP	NA	1380	118747	39948	2701	2050	836	168808
bsdb:207/1/2_Vulvovaginitis:Women-with-BV_vs_Normal-controls_DOWN	NA	1578
bsdb:207/2/1_Vulvovaginitis:Women-with-BV-and-VVC_vs_Normal-controls_UP	NA	838
bsdb:208/1/1_Food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	207244	1485	1350	216851	946234	1578	838	1279
bsdb:208/1/2_Food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	816	572511	158846	906	1301	29465
bsdb:208/2/1_Food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	580596	1485
bsdb:208/2/2_Food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	906	68287	222	84111	237	40323	86331	59732	283
bsdb:208/3/1_Food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/3/2_Food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:208/4/1_Food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/4/2_Food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:209/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	29465	407	544	1279	1716	1301	12916	1743	117563	469	374	80865	1302778	1578	222	65551	28209	40323	114248	724	88	283	28067	504481	1357	547	150247	357
bsdb:209/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	561	816	1485	1678	1350	544	570	158851	620	1279	1716	1301
bsdb:210/1/1_Food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	239934	1678	102106	1350	216851	1578	841	1263	13687	292632	40544
bsdb:210/1/2_Food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	239759	816	375288	838	1301	29465
bsdb:210/2/1_Food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	292632
bsdb:210/2/2_Food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	816	29465
bsdb:211/1/1_Anemia:gestational-anemia-(GA1-group)_vs_healthy-controls(HC1-group)_UP	NA	244127	265975	543311	191303
bsdb:211/2/1_Anemia:gestational-anemia-(GA3-group)_vs_healthy-controls-(HC3-group)_UP	NA	1380	135858	84111
bsdb:211/2/2_Anemia:gestational-anemia-(GA3-group)_vs_healthy-controls-(HC3-group)_DOWN	NA	216851	1263	86331	207244	204475	447020
bsdb:212/1/1_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	1654	283168	119852
bsdb:212/1/2_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	216851	28050
bsdb:212/2/1_Diet:Higher-fiber-intake-from-FRUITS/-VEGETABLES_vs_low-fiber-intake-from-FRUITS/-VEGETABLES_DOWN	NA	1654	283168
bsdb:212/3/1_Diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_UP	NA	33042	216851
bsdb:212/3/2_Diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_DOWN	NA	816	283168	1263
bsdb:212/4/1_Diet:Higher-fiber-intake-from-GRAINS_vs_low-fiber-intake-from-GRAINS_DOWN	NA	572511
bsdb:213/4/1_Gut-microbiome-measurement:2-month-old-infants_vs_Neonates_UP	NA	29465	1485	1578	838	1678
bsdb:213/5/1_Delivery-method:Vaginally-delivered-neonates_vs_Cesarean-delivered-neonates_UP	NA	816	158846	375288
bsdb:213/5/2_Delivery-method:Vaginally-delivered-neonates_vs_Cesarean-delivered-neonates_DOWN	NA	1301	158851
bsdb:213/6/1_Delivery-method:Vaginally-delivered-2-month-olds_vs_Cesarean-delivered-2-month-olds_UP	NA	816	158846
bsdb:213/6/2_Delivery-method:Vaginally-delivered-2-month-olds_vs_Cesarean-delivered-2-month-olds_DOWN	NA	1485	838
bsdb:214/1/1_Milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	547	590	158851
bsdb:214/1/2_Milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	572511	1730	1263
bsdb:215/1/1_Eczema:infants-with-eczema_vs_healthy-control-infants_UP	NA	239934	207244	35832	33042	872	547	216851	946234	204475	44249	375288	577309	33024	836	379	841	29465	561	620	1485
bsdb:215/1/2_Eczema:infants-with-eczema_vs_healthy-control-infants_DOWN	NA	904	209879	156454	244127	1678	43668	1696	580596	1485	102106	1716	39948	189330	538	117563	724	570	1578	906	459786	838	1263	1301	40544	191303
bsdb:216/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1380	1350
bsdb:217/3/1_Age:infant-at-18-months_vs_infant-at-6-months_UP	NA	848	583
bsdb:217/3/2_Age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	1678
bsdb:218/1/1_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_UP	NA	244127
bsdb:218/1/2_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_DOWN	NA	28050	158846
bsdb:218/2/1_Hepatocellular-carcinoma:HBV-related-HCC-patients_vs_healthy-controls_UP	NA	244127	33024	838
bsdb:218/3/1_Hepatocellular-carcinoma:non-HBV-non-HCV-patients_vs_HBV-related-HCC-patients_DOWN	NA	32199	28050	33024
bsdb:219/2/1_Diet:lower-fiber-(cracker)---8-wk-after-intervention_vs_higher-fiber-(almonds)---8-wk-after-intervention_UP	NA	28050
bsdb:219/2/2_Diet:lower-fiber-(cracker)---8-wk-after-intervention_vs_higher-fiber-(almonds)---8-wk-after-intervention_DOWN	NA	239759	574697	283168
bsdb:219/3/1_Diet:lower-fiber-(cracker)_vs_higher-fiber-(almonds)_DOWN	NA	40544
bsdb:220/1/1_Age:older-age-European-women_vs_younger-age_UP	NA	1663	168808	1716	2745
bsdb:220/1/2_Age:older-age-European-women_vs_younger-age_DOWN	NA	1743
bsdb:221/1/1_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_UP	NA	547
bsdb:221/1/2_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_DOWN	NA	39948	150022	724	149698
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	1350	1506553	1578	1301
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	816	39948	216851	158846	33024	838	292632
bsdb:223/2/1_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_UP	NA	1350	1505663
bsdb:223/2/2_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_DOWN	NA	39948	216851	33024	838
bsdb:223/3/1_HIV-infection:Intravenous-drug-abuse-HIV-patients_vs_healthy-controls_UP	NA	1578	1301
bsdb:223/4/1_HIV-infection:homosexual-subjects-with-HIV_vs_heterosexual-subjects-with-HIV_DOWN	NA	1506553	375288	33024	838
bsdb:223/5/1_HIV-infection:HAART-treated-HIV+-patients_vs_healthy-control_UP	NA	561	1506553	620	1301
bsdb:223/5/2_HIV-infection:HAART-treated-HIV+-patients_vs_healthy-control_DOWN	NA	816	39948	216851	158846	33024	838	292632
bsdb:223/6/1_HIV-infection:HAART-untreated_vs_healthy-control_UP	NA	1350	1578
bsdb:224/1/1_Diet:barley-(WGB)_vs_baseline_UP	NA	572511
bsdb:224/1/2_Diet:barley-(WGB)_vs_baseline_DOWN	NA	283168	841	39948
bsdb:224/3/1_Diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_UP	NA	572511
bsdb:224/3/2_Diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_DOWN	NA	816
bsdb:225/1/1_Atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_UP	NA	1350
bsdb:225/2/1_Atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_DOWN	NA	816
bsdb:226/1/1_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_UP	NA	580596	135858	189330	547	1350	216851	158846	577310	838
bsdb:226/1/2_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_DOWN	NA	33042	397864	39948	816
bsdb:226/2/1_HIV-infection:HAART-treated-HIV-1-patients_vs_HAART-naive-HIV-1-patients_UP	NA	1654	572511	1350	158846	29465
bsdb:226/2/2_HIV-infection:HAART-treated-HIV-1-patients_vs_HAART-naive-HIV-1-patients_DOWN	NA	239759	397864	39948	216851	283168	459786	838	638847
bsdb:227/1/2_Atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678	239934
bsdb:227/2/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301
bsdb:227/2/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1485
bsdb:227/3/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	1301
bsdb:227/3/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934
bsdb:227/4/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301	1505657	216851	375288	1505652	1501226	117563	100883
bsdb:227/4/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1654	544	100883	84111	547	1330547	1504576	160674	1485
bsdb:227/5/1_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	100883	189330	216851	375288	1501226	1301	469
bsdb:227/5/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934	547	1330547	160674	2735
bsdb:227/6/1_Atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678
bsdb:227/6/2_Atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_DOWN	NA	32207
bsdb:228/1/1_Diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	841	816	44748
bsdb:229/1/1_Diet:early-pectin-incubation-time_vs_late-pectin-incubation-time_UP	NA	1678	100883	846	283168	33042	574697	1263	207244	572511	375288	33024	841	816
bsdb:229/1/2_Diet:early-pectin-incubation-time_vs_late-pectin-incubation-time_DOWN	NA	28050	40544	189330	1485
bsdb:230/1/1_Food-allergy:infant-with-food-allergy_vs_non-allergy_DOWN	NA	1243	46255	29465
bsdb:230/1/2_Food-allergy:infant-with-food-allergy_vs_non-allergy_UP	NA	1485
bsdb:231/1/1_Diet:Renatta-canada-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	35832	119852	375288	1263	86331
bsdb:231/1/2_Diet:Renatta-canada-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	1678
bsdb:231/2/1_Diet:Golden-delicious-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	86331	119852	1263	375288	35832
bsdb:231/2/2_Diet:Golden-delicious-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	1678
bsdb:231/3/1_Diet:Pink-lady-apple---at-10-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	86331	119852	1263	375288	35832
bsdb:231/4/1_Diet:Renetta-Canada-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	574697
bsdb:231/4/2_Diet:Renetta-Canada-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	216851	1678
bsdb:231/5/1_Diet:Golden-delicious-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	574697
bsdb:231/5/2_Diet:Golden-delicious-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	1678
bsdb:231/6/1_Diet:Pink-lady-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_DOWN	NA	574697
bsdb:231/6/2_Diet:Pink-lady-apple--at-24-hr_vs_Poorly-fermentable-fiber-(cellulose)_UP	NA	216851
bsdb:231/7/1_Diet:Renatta-canada-apple---at-10-hr_vs_Inulin_DOWN	NA	119852	86331
bsdb:231/7/2_Diet:Renatta-canada-apple---at-10-hr_vs_Inulin_UP	NA	1678
bsdb:231/8/1_Diet:Golden-delicious-apple---at-10-hr_vs_Inulin_DOWN	NA	86331	119852
bsdb:231/8/2_Diet:Golden-delicious-apple---at-10-hr_vs_Inulin_DOWN	NA	1678
bsdb:231/9/1_Diet:Golden-delicious-apple---at-24-hr_vs_Inulin_UP	NA	216851
bsdb:231/10/1_Diet:Pink-Lady-apple---at-10-hr_vs_Inulin_DOWN	NA	86331	119852
bsdb:231/11/1_Diet:Pink-Lady-apple---at-24-hr_vs_Inulin_DOWN	NA	216851
bsdb:231/12/1_Diet:Cellulose---at-10hr_vs_Inulin_UP	NA	35832	119852	375288
bsdb:231/13/1_Diet:Cellulose---at-24hr_vs_Inulin_DOWN	NA	216851
bsdb:232/1/1_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_UP	NA	165779	848	1257	836
bsdb:232/1/2_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_DOWN	NA	239759	33042	1730	28050	841	1263
bsdb:233/1/1_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_UP	NA	469	838
bsdb:233/1/2_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_DOWN	NA	816	572511	33042
bsdb:236/1/1_Diet:before-walnut-diet_vs_after-walnut-diet_UP	NA	207244
bsdb:236/1/2_Diet:before-walnut-diet_vs_after-walnut-diet_DOWN	NA	1678	572511
bsdb:236/2/1_Diet:carbohydrate-replacement-(with-walnuts)_vs_replace-both_DOWN	NA	204475	1407607	816
bsdb:236/3/1_Diet:replace-both_vs_fat-replacement-(with-walnuts)_UP	NA	204475	1407607	816
bsdb:237/1/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	239934	1283313	544	724	1578	1269	1253	1301	29465	46255	1485
bsdb:237/1/2_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_DOWN	NA	35829	35832	574697	52225	1017280	213484	172900
bsdb:237/2/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_UP	NA	1578	29465	1678	239934	724	1269	46255
bsdb:237/2/2_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_DOWN	NA	213484
bsdb:237/3/1_Chronic-hepatitis-C-virus-infection:No-cirrhosis_vs_healthy-controls_DOWN	NA	52225	946234	906	35829
bsdb:237/3/2_Chronic-hepatitis-C-virus-infection:No-cirrhosis_vs_healthy-controls_UP	NA	1283313	1578	1301	29465	1485
bsdb:238/1/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	40544	1505663	437755	946234	459786	1301
bsdb:238/1/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759	207244	816	572511	547	561	1407607	1505657	375288	1501226	620	574697
bsdb:238/2/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1505663	946234	437755
bsdb:238/2/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1501226	207244	572511	239759
bsdb:238/3/1_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1301	1505663	437755
bsdb:238/3/2_Cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1505657	1501226	1407607	207244	547	239759
bsdb:239/1/1_Egg-allergy:children-with-egg-allergy_vs_healthy-control_UP	NA	1263	1357
bsdb:239/1/2_Egg-allergy:children-with-egg-allergy_vs_healthy-control_DOWN	NA	1243
bsdb:239/2/1_Egg-allergy:children-with-egg-sensitization_vs_healthy-control_UP	NA	216851	841
bsdb:241/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	39948
bsdb:242/1/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	475	1357	286	1350	57493	1578
bsdb:242/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	1716	482	416916	2717
bsdb:242/2/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	1350	57493	1357	475	286
bsdb:242/2/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	194	2717	32207	416916	215579	1016	482	1716
bsdb:242/3/1_Iron-deficiency-anemia:iron-deficiency-anemia-severe_vs_iron-deficiency-anemia-moderate_UP	NA	57493	1111	1279	475	1350	286	1357
bsdb:243/1/1_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_UP	NA	1378
bsdb:243/1/2_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_DOWN	NA	12916	1827
bsdb:243/2/1_Gastric-cancer:current-H.pylori-infection-patients_vs_past-H.pylori-infection_UP	NA	838	40544
bsdb:243/3/1_Gastric-cancer:past-H.pylori-infection_vs_H.pylori-negative_DOWN	NA	375288
bsdb:243/4/1_Gastric-cancer:gastritis-cases_vs_normal_UP	NA	244127	189330	561	216851	620	1301	191303
bsdb:243/5/1_Gastric-cancer:subjects-with-metaplasia_vs_normal_UP	NA	39948	189330	1506553	1501226	191303
bsdb:244/1/1_Age:18-62-years_vs_2-12-years_UP	NA	1743	1716	1279	1578	150022	165779
bsdb:244/1/2_Age:18-62-years_vs_2-12-years_DOWN	NA	32207	1301	117563	1378	724
bsdb:244/2/1_Atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1279
bsdb:244/2/2_Atopic-eczema:lesional-skin_vs_non-lesional-skin_DOWN	NA	1301	1743
bsdb:244/3/1_Age:13-62-years_vs_2-12-years_UP	NA	1743	1716	1578
bsdb:244/3/2_Age:13-62-years_vs_2-12-years_DOWN	NA	1301	117563	1378	482	724	32207	29465
bsdb:245/1/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	469	1283313	85413	561	1730	1573534	1506553	158846	620
bsdb:245/1/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	1508657	39948	61170	168934	638847	1678	841	577310	547
bsdb:245/2/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	1283313	1505663	33024	158846	469	561	620	40544
bsdb:245/2/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	189330	1508657	207244	1407607	292632	1573535	39948	1263	577310	35832
bsdb:246/1/1_Asthma:maternal-asthma/male-caucasian-infants_vs_no-asthma_UP	NA	1654	1357	158846
bsdb:246/1/2_Asthma:maternal-asthma/male-caucasian-infants_vs_no-asthma_DOWN	NA	158851	1578
bsdb:246/2/1_Asthma:maternal-asthma_vs_no-asthma_UP	NA	816	286
bsdb:246/2/2_Asthma:maternal-asthma_vs_no-asthma_DOWN	NA	906
bsdb:246/4/1_Asthma:maternal-asthma/caucasian-infants_vs_no-asthma_DOWN	NA	1578
bsdb:246/5/1_Asthma:maternal-asthma/female-infants_vs_no-asthma_UP	NA	816	189330
bsdb:246/6/1_Asthma:maternal-asthma/caucasian-infants/allergies_vs_no-asthma_DOWN	NA	1578	906
bsdb:246/7/1_Asthma:maternal-asthma/caucasian-infants/no-allergies_vs_no-asthma_UP	NA	239934
bsdb:246/7/2_Asthma:maternal-asthma/caucasian-infants/no-allergies_vs_no-asthma_DOWN	NA	1654
bsdb:246/8/1_Asthma:overweight-prenatal-asthma-caucasian-mothers_vs_no-asthma_DOWN	NA	1578	906
bsdb:247/1/1_Diet:Placebo_vs_Prebiotic_UP	NA	33042	189330	119852
bsdb:247/1/2_Diet:Placebo_vs_Prebiotic_DOWN	NA	1678
bsdb:247/2/1_Diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-low-dietary-fiber_DOWN	NA	1678
bsdb:247/3/1_Diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_UP	NA	572511	33042	189330
bsdb:247/3/2_Diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_DOWN	NA	1678
bsdb:247/4/1_Diet:High-dietary-fiber_vs_Low-dietary-fiber_UP	NA	216851
bsdb:247/4/2_Diet:High-dietary-fiber_vs_Low-dietary-fiber_DOWN	NA	1578
bsdb:248/1/1_Human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_UP	NA	33870
bsdb:248/1/2_Human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_DOWN	NA	724	28100
bsdb:248/2/1_Human-papilloma-virus-infection:HPV_vs_no-HPV_UP	NA	2701
bsdb:248/2/2_Human-papilloma-virus-infection:HPV_vs_no-HPV_DOWN	NA	286	28100
bsdb:249/1/1_Hepatitis,-Alcoholic:alcoholics_vs_NAC_UP	NA	374	33882	1843210	1716
bsdb:249/1/2_Hepatitis,-Alcoholic:alcoholics_vs_NAC_DOWN	NA	2053	1839	53387	1678	816	397864	577309	838	239759	237	182709	94008	572511	1263	186650	265	780	114248	12916	47420	215579	29580	70774	642
bsdb:249/2/1_Hepatitis,-Alcoholic:HDC_vs_NAC_UP	NA	469	165779	374	59732	57493	33882	482	20	1883	1060
bsdb:249/2/2_Hepatitis,-Alcoholic:HDC_vs_NAC_DOWN	NA	2053	1839	1678	816	397864	838	237	1301	1485	114248	12916	70774
bsdb:249/3/1_Hepatitis,-Alcoholic:MAH_vs_NAC_UP	NA	469	1654	165779	374	501783	1716	281915	117563	407
bsdb:249/3/2_Hepatitis,-Alcoholic:MAH_vs_NAC_DOWN	NA	1839	53387	838	237	1386	1485	29580	70774
bsdb:249/4/1_Hepatitis,-Alcoholic:SAH_vs_NAC_UP	NA	1654	1651	43668	1716	244698	33882
bsdb:249/4/2_Hepatitis,-Alcoholic:SAH_vs_NAC_DOWN	NA	1839	1678	397864	239759	237
bsdb:250/1/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_UP	NA	482	1213720
bsdb:250/2/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	482
bsdb:251/1/1_Milk-allergic-reaction:cows-milk-allergic-(CMA)-infants-colonized-mice_vs_healthy-Infants-colonised-mice_UP	NA	572511	100883	1350	375288	1263
bsdb:251/1/2_Milk-allergic-reaction:cows-milk-allergic-(CMA)-infants-colonized-mice_vs_healthy-Infants-colonised-mice_DOWN	NA	590	1301
bsdb:252/1/1_Pemphigus-vulgaris:Pemphigus-vulgaris-(PV)--Patients_vs_healthy-control_UP	NA	46123	100883	946234	117563
bsdb:252/1/2_Pemphigus-vulgaris:Pemphigus-vulgaris-(PV)--Patients_vs_healthy-control_DOWN	NA	102106	33042
bsdb:253/1/1_Asthma:asthma_vs_healthy-control_UP	NA	1279	838
bsdb:253/1/2_Asthma:asthma_vs_healthy-control_DOWN	NA	724
bsdb:253/2/1_Asthma:asthma-remission_vs_healthy-control_UP	NA	848	838	543311
bsdb:253/2/2_Asthma:asthma-remission_vs_healthy-control_DOWN	NA	724
bsdb:254/1/1_Nephrolithiasis,Urolithiasis:kidney-stone-patient_vs_healthy-control_UP	NA	239759	816	375288
bsdb:254/1/2_Nephrolithiasis,Urolithiasis:kidney-stone-patient_vs_healthy-control_DOWN	NA	150022	162289	838	184869
bsdb:255/1/1_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1279
bsdb:255/1/2_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/2/1_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1301	543311
bsdb:255/2/2_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/3/1_HIV-infection:HIV+_vs_HIV-_UP	NA	1375	1378	117563	437755	1257	1279	1301
bsdb:255/3/2_HIV-infection:HIV+_vs_HIV-_DOWN	NA	28263	2129	1678
bsdb:256/1/1_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	45402	2745	209	1578	407	1257	970	22	1301	29465
bsdb:256/1/2_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	1386	816	1716	216851	848	33024	838	1743	286	13687
bsdb:256/2/1_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	1386	838	1743	286
bsdb:256/2/2_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	216851	2745	33024	22	13687
bsdb:256/3/1_Gastric-cancer:tumoral-tissues_vs_normal-tissues_UP	NA	1386	1716	848	2745	1578	1743	970	22	1301
bsdb:256/3/2_Gastric-cancer:tumoral-tissues_vs_normal-tissues_DOWN	NA	816	209	286	13687
bsdb:256/9/1_Gastric-cancer:normal-HP+_vs_normal-HP-_UP	NA	149698	1678	1716	1654	407	13687	1301	209
bsdb:256/9/2_Gastric-cancer:normal-HP+_vs_normal-HP-_DOWN	NA	572511	39948	216851	204475	2745	33024	838	841	1263	22
bsdb:256/10/1_Gastric-cancer:peritumor-HP+_vs_peritumor-HP-_UP	NA	1386	1378	209	1301
bsdb:256/10/2_Gastric-cancer:peritumor-HP+_vs_peritumor-HP-_DOWN	NA	33024	841	216851	239759	39948	204475	158846	1386	375288
bsdb:256/11/1_Gastric-cancer:tumor-HP+_vs_tumor-HP-_UP	NA	1279	816	41275	572511	149698	165696	209
bsdb:256/11/2_Gastric-cancer:tumor-HP+_vs_tumor-HP-_DOWN	NA	469	1263	286	13687	1678
bsdb:257/1/1_Colorectal-cancer:colorectal-cancer_vs_healthy-control_UP	NA	239934	35832	574697	990721	1485	51514	848	283168	119852	846	375288	1257	836	1263	970	1730
bsdb:257/1/2_Colorectal-cancer:colorectal-cancer_vs_healthy-control_DOWN	NA	158846	52225
bsdb:258/1/1_Colorectal-cancer:carcinoma_vs_Healthy-Controls_UP	NA	848	836	1485
bsdb:258/1/2_Colorectal-cancer:carcinoma_vs_Healthy-Controls_DOWN	NA	816	1279	1485
bsdb:258/2/1_Colorectal-cancer:Adenoma_vs_Healthy-Controls_UP	NA	1485	286
bsdb:258/2/2_Colorectal-cancer:Adenoma_vs_Healthy-Controls_DOWN	NA	816	1485	283168
bsdb:258/3/1_Colorectal-cancer:Colonic-lesions_vs_Healthy-Controls_UP	NA	286
bsdb:258/3/2_Colorectal-cancer:Colonic-lesions_vs_Healthy-Controls_DOWN	NA	816	1485
bsdb:258/4/1_Colorectal-cancer:Carcinoma_vs_Adenoma_UP	NA	816	1485	848	577310	33024	836
bsdb:258/4/2_Colorectal-cancer:Carcinoma_vs_Adenoma_DOWN	NA	572511	1263	1485
bsdb:260/1/2_Food-allergy:Allergic-Estonian-children._vs_Nonallergic--Estonian-children._DOWN	NA	1678	1578
bsdb:260/2/2_Food-allergy:Allergic-Swedish-children_vs_Non-allergic-Swedish-children._DOWN	NA	1578	1678
bsdb:262/1/1_Atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_UP	NA	1651	1716	475	1279
bsdb:262/1/2_Atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_DOWN	NA	1654	32067	836	838	1301
bsdb:262/2/1_Atopic-asthma:oral-wash-specimens_vs_bronchial-brush-specimens_UP	NA	1654	32067	1301
bsdb:262/2/2_Atopic-asthma:oral-wash-specimens_vs_bronchial-brush-specimens_DOWN	NA	1716	475	838	1279
bsdb:262/3/1_Atopic-asthma:induced-sputum-specimens_vs_nasal-brush-specimens_UP	NA	1654	32067	836	838	1301
bsdb:262/3/2_Atopic-asthma:induced-sputum-specimens_vs_nasal-brush-specimens_DOWN	NA	1651	1716	475	1279
bsdb:262/4/1_Atopic-asthma:oral-wash-specimens_vs_nasal-brush-specimens_UP	NA	1654	32067	836	838	1301
bsdb:262/4/2_Atopic-asthma:oral-wash-specimens_vs_nasal-brush-specimens_DOWN	NA	1651	1716	475	1279
bsdb:262/5/1_Atopic-asthma:oral-wash-specimens_vs_induced-sputum-specimens_UP	NA	1654
bsdb:262/5/2_Atopic-asthma:oral-wash-specimens_vs_induced-sputum-specimens_DOWN	NA	1716	838	1279
bsdb:262/6/1_Atopic-asthma:induced-sputum-specimens_vs_bronchial-brush-specimens_UP	NA	32067	1301
bsdb:262/7/1_Atopic-asthma:atopic-asthma-subjects_vs_healthy-controls_UP	NA	1279	1716	47420
bsdb:263/1/1_Crohn's-disease:crohn's-disease_vs_healthy-controls_UP	NA	1654	572511	84111	1573536	1378	1505657	32207	1301
bsdb:263/1/2_Crohn's-disease:crohn's-disease_vs_healthy-controls_DOWN	NA	553372	1485	33042	216851	1407607	204475	28050	86331	459786	1501226	1263	44748	292632	191303
bsdb:263/2/1_Ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_UP	NA	1654	264995	1678	84111	1573536	1378	1301
bsdb:263/2/2_Ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_DOWN	NA	204475	644652	28050	86331	1263	44748
bsdb:263/3/1_Multiple-sclerosis:multiple-sceloris_vs_healthy-controls_UP	NA	1654	264995	1485	84111	1573536	1301	191303
bsdb:263/3/2_Multiple-sclerosis:multiple-sceloris_vs_healthy-controls_DOWN	NA	580596	39948	216851	1407607	204475	28050	100132	292632
bsdb:263/4/1_Rheumatoid-arthritis:arthiritis_vs_healthy-controls_UP	NA	1654	84111	1573536	1378	32207	1301
bsdb:263/4/2_Rheumatoid-arthritis:arthiritis_vs_healthy-controls_DOWN	NA	264995	580596	1485	216851	1407607	204475	28050	1501226	841	44748	292632
bsdb:264/1/1_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	28263	39948	906	162289	1257	838	168808
bsdb:264/1/2_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	56688	1578
bsdb:265/1/1_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_UP	NA	32207	1301	29465	724	150022
bsdb:265/1/2_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_DOWN	NA	357	816	80865	1578	906	1743	286	1279
bsdb:265/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	400634	2129
bsdb:265/2/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	29465
bsdb:266/1/1_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_UP	NA	1301	838	570	216851	841	572511
bsdb:266/1/2_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_DOWN	NA	239934	239759	816	1678	1485	33042	39948	158846	459786	375288	33024	590
bsdb:267/1/1_Atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	1654	109326	194	848	724	32257	482	836	838	165697	157	29465
bsdb:267/1/2_Atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	713	1578	32067	407	1257
bsdb:267/2/1_Atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	1654	416916	1716	2353	848	117563	724	475	970	519427	165697	29465
bsdb:267/2/2_Atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	209	1578	32067	543311	836	838	286	1301
bsdb:267/3/1_Atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	39948	848	724	32067	2093	838	970
bsdb:267/3/2_Atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	416916	174708	1716	2353	1578	836	519427	165697	1301
bsdb:267/4/1_Atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_UP	NA	86331	1301
bsdb:267/4/2_Atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_DOWN	NA	1378
bsdb:267/5/1_Atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline-(corticosteroid-treatment-group)_UP	NA	482	475
bsdb:267/5/2_Atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline-(corticosteroid-treatment-group)_DOWN	NA	848	39948
bsdb:267/6/1_Atopic-asthma:post-placebo-treatment_vs_baseline-(placebo-group)_UP	NA	538
bsdb:267/6/2_Atopic-asthma:post-placebo-treatment_vs_baseline-(placebo-group)_DOWN	NA	469
bsdb:268/1/1_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	1485	102106	1716	168808	29465
bsdb:268/1/2_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_DOWN	NA	1279	48736
bsdb:269/1/1_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	816
bsdb:269/1/2_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	194	1716	1678	1380	162289	1279	838	165779	836
bsdb:269/1/3_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	1678
bsdb:269/1/4_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	1380	816	838	848	1716
bsdb:270/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808	906	1253	1696	286
bsdb:270/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	83618	1654	213484	222991
bsdb:270/2/1_Human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_UP	NA	1380	216851
bsdb:270/2/2_Human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_DOWN	NA	28065
bsdb:271/1/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	216851	253238	44748
bsdb:271/1/2_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	32207
bsdb:271/2/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	1730	216851
bsdb:272/1/1_Pneumonia:S.pneumoniae-positive_vs_negative_UP	NA	475	1301
bsdb:272/1/2_Pneumonia:S.pneumoniae-positive_vs_negative_DOWN	NA	1716	1279
bsdb:273/1/1_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	1678	816	838	239759	189330	216851
bsdb:273/1/2_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_UP	NA	357	507	41275	517
bsdb:274/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	838
bsdb:274/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1654	1678	39948	2701	1578
bsdb:274/2/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	543311
bsdb:274/2/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	71655	561	1578	162289	620	1301
bsdb:274/3/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	1380	1485	2701	906	543311	177971	168808
bsdb:274/3/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1678	39948	1578	836	1301	2129
bsdb:274/4/2_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	1678	71655	1716	39948	561	404402	1578	620	1301	2129
bsdb:274/5/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	906	133925	838	177971
bsdb:274/5/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1375	165779	1678	2701
bsdb:274/6/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	1678	1485	39948	1578	836	838	168808
bsdb:274/6/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	1578
bsdb:274/7/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	1485	2701	906	543311	177971	168808
bsdb:274/7/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1375	165779	1678	39948	162290	2701	404402	836
bsdb:274/8/1_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	165779	1678	2701	1578	437755
bsdb:274/9/1_Human-papilloma-virus-infection,Cervical-cancer:normal-pH_vs_abnormal-pH_UP	NA	1380	1678	1485	1350	2701	1378	906	437755	543311	1257	838	177971	168808	1279	1301	29465
bsdb:274/9/2_Human-papilloma-virus-infection,Cervical-cancer:normal-pH_vs_abnormal-pH_DOWN	NA	71655	1485	561	1578	620
bsdb:274/10/1_Human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_UP	NA	1375	1380	1350	2701	906	437755	836	177971	168808	1301	29465
bsdb:274/10/2_Human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_DOWN	NA	1578
bsdb:275/1/1_Acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_UP	NA	816
bsdb:275/1/2_Acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_DOWN	NA	841
bsdb:276/2/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	816	191303	413496
bsdb:276/2/2_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1508657	1730	207244	84108	135858	904
bsdb:276/3/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	816	216851	841	29465	904	1472649	830	174708
bsdb:276/3/2_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1481960
bsdb:277/1/1_Crohn's-disease:crohn's-disease_vs_healthy-control_DOWN	NA	216851	1263	841	239759	1730	46239	206664	836	28138	375288	830
bsdb:278/1/1_Non-alcoholic-fatty-liver-disease:NAFLD--[non-alcoholic-fatty-liver-disease]_vs_Healthy-control_UP	NA	1578
bsdb:278/1/2_Non-alcoholic-fatty-liver-disease:NAFLD--[non-alcoholic-fatty-liver-disease]_vs_Healthy-control_DOWN	NA	239759	207244	816	572511	189330	216851	33042	841	375288
bsdb:279/1/2_Acute-myeloid-leukemia:High-Intensity-Chemotherapy_vs_Low-Intensity-Chemotherapy_DOWN	NA	55193
bsdb:279/2/1_Acute-myeloid-leukemia:Patients-with-bacterial-infections-at-T3_vs_Patients-without-bacterial-infections-at-T3_UP	NA	1535326
bsdb:279/3/1_Acute-myeloid-leukemia:Patients-with-bacterial-infections-at-T6_vs_Patients-with-no-bacterial-infections-at-T6_DOWN	NA	5506
bsdb:279/4/1_Antimicrobial-agent:Patients-who-received-Amphotericin-B_vs_Patients-who-did-not-receive-Amphotericin-B_UP	NA	5506
bsdb:280/1/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_UP	NA	165779	168808
bsdb:281/1/1_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Healthy-Control_UP	NA	239934	2086	207244	572511	830	1485	33042	189330	119852	1263
bsdb:281/1/2_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Healthy-Control_DOWN	NA	447020	1578	191303
bsdb:281/2/1_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-of-leukemia-mice_vs_Healthy-Control_UP	NA	1279	1301	48736	1357
bsdb:281/2/2_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-of-leukemia-mice_vs_Healthy-Control_DOWN	NA	1578	1883	848	191303	239934
bsdb:282/1/2_Graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_DOWN	NA	1506553	572511
bsdb:283/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	84111	1378
bsdb:284/1/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1654	59735	1716	32207	1301	1578
bsdb:284/1/2_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	848	836
bsdb:285/1/1_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	35832	1678	872	135858	33024
bsdb:285/1/2_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	28050	577309	816	119852
bsdb:285/3/1_Multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_UP	NA	904	1380	1678	35832	135858	33042	872	189330	1730	158846	906	2172	119852	33024	113286	1263	40544
bsdb:285/3/2_Multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_DOWN	NA	577309	816	1263	574697	33042	207244	40544	135858	39948	189330
bsdb:286/1/2_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	207244	572511	574697	102106	1407607	1263
bsdb:288/1/1_Phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	841	1578
bsdb:289/1/1_Health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	59732	119852	841	1263
bsdb:289/1/2_Health-trait:suboptimal-health-status_vs_healthy-controls_DOWN	NA	581	48736	40544
bsdb:290/1/1_Oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_UP	NA	29465	1350	1301	1279	848	838
bsdb:290/1/2_Oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_DOWN	NA	1301	1654
bsdb:290/2/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	838	32067
bsdb:290/2/2_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1578
bsdb:290/3/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	1654
bsdb:290/4/1_Oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_UP	NA	196081	1279	1578
bsdb:290/4/2_Oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_DOWN	NA	29465	1654	838	32067	906	1301
bsdb:291/1/1_Graves-disease:graves-disease_vs_healthy-controls_UP	NA	838	724
bsdb:291/1/2_Graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	239759	216851	39948
bsdb:292/1/2_Response-to-allogeneic-hematopoietic-stem-cell-transplant:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling-controls_DOWN	NA	1283313	724	32067	482	265975	838	1301
bsdb:293/1/1_Human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_UP	NA	2129
bsdb:293/1/2_Human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_DOWN	NA	1582879	216851	848	873565
bsdb:293/2/1_Human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_DOWN	NA	1654
bsdb:295/1/1_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_UP	NA	1654	239759	1678	35832	572511	574697	1485	1348911	33042	39948	1407607	204475	70774	906	745	1257	33024	841	1263	1200657	168808	40544
bsdb:295/1/2_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	209	68	497726
bsdb:297/1/1_Human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_UP	NA	1678	1386
bsdb:297/1/2_Human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_DOWN	NA	1578
bsdb:297/2/1_Human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_UP	NA	12916
bsdb:297/2/2_Human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_DOWN	NA	1301
bsdb:298/2/1_Acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	40323
bsdb:298/2/2_Acute-myeloid-leukemia:infection_vs_no-infection_DOWN	NA	1301
bsdb:298/3/1_Acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	40323
bsdb:301/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	39948	906	168808	848
bsdb:301/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1578
bsdb:301/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808
bsdb:301/3/1_Human-papilloma-virus-infection:HR-HPV+_vs_HPV-_UP	NA	168808
bsdb:302/3/1_Asthma:exacerbated-asthma_vs_non-exacerbated-asthma_UP	NA	838	222991	2701
bsdb:302/3/2_Asthma:exacerbated-asthma_vs_non-exacerbated-asthma_DOWN	NA	39948
bsdb:303/1/1_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	544	1350	375288	1380	570
bsdb:303/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	447020	165779	1380	1678	572511	1485	102106	33042	189330	570	28050	119852	841	1263
bsdb:304/1/1_Antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	1380	1678	102106
bsdb:305/1/1_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_UP	NA	165779	39948	1582879	848	2050	437755	2093	543311	162289	1257	836	838	168808
bsdb:305/1/2_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_DOWN	NA	1678	1578	177971
bsdb:307/1/1_Antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_UP	NA	572511
bsdb:307/1/2_Antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	239759	572511	574697	135858	1485	100883	1730	216851	459786
bsdb:307/2/1_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_UP	NA	239759	216851	572511	459786	100883	1730	574697	135858
bsdb:307/2/2_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_DOWN	NA	572511
bsdb:307/3/2_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_DOWN	NA	135858
bsdb:308/1/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1578
bsdb:308/1/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578	1279
bsdb:308/2/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	28050	816
bsdb:308/2/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	816	1279	1578	191303
bsdb:308/3/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	816	119852	1263	1279	191303
bsdb:308/4/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578
bsdb:308/5/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	375288
bsdb:308/5/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	2086	1485	191303
bsdb:308/6/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578	1279
bsdb:309/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	816	574697	1578	375288	59195
bsdb:309/2/1_Cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_UP	NA	357	665874	20	286
bsdb:310/1/1_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	816	561
bsdb:310/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	572511	216851	841	1678
bsdb:312/2/1_Antimicrobial-agent:Infants-born-by-mothers-positive-to-GBS-and-received-IAP_vs_infants-born-by-mothers-negative-to-GBS_DOWN	NA	1678
bsdb:313/1/1_Non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_UP	NA	29465
bsdb:313/1/2_Non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_DOWN	NA	574697	51514	216851	119852	40544
bsdb:314/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	1380	168808	906	543311	838
bsdb:314/1/2_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_DOWN	NA	1578
bsdb:316/4/1_Delivery-method:10-day-old-vaginally-delivered-pre-term-neonates_vs_10-day-old-cesarean-delivered-pre-term-neontes_UP	NA	816
bsdb:316/11/1_Antimicrobial-agent:90-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP/postnatal)_vs_90-day-old-pre-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	1678
bsdb:317/1/1_Obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_UP	NA	239759	207244	1348911	946234	1649459	459786
bsdb:317/1/2_Obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_DOWN	NA	1766253	580596	135858	1485	33042	39948	404402	28050	577309	1501226
bsdb:317/2/1_Obsessive-compulsive-disorder:OCD-T0_vs_Control-(healthy-group)_UP	NA	265975	1654	1380	1164882	86331
bsdb:317/3/1_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_UP	NA	239759	207244	244127	35832	1348911	1432051	946234	61170	1649459	459786	1929305	1508657
bsdb:317/3/2_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_DOWN	NA	135858	33042	1505657	577309	1501226
bsdb:317/4/1_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_UP	NA	1654	1380	43996	86331
bsdb:317/4/2_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_DOWN	NA	830	1716	43994
bsdb:318/2/1_Graft-versus-host-disease:acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	216851	1730
bsdb:319/1/1_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	248744	2093
bsdb:319/1/2_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	209	1501226	100175	174708	191303
bsdb:320/1/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/1/2_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841	1263
bsdb:320/2/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/2/2_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841
bsdb:320/3/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to--antibiotic-penicillin_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_DOWN	NA	816	1678
bsdb:320/4/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_UP	NA	33042
bsdb:320/4/2_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_DOWN	NA	816	1485	158846	1301
bsdb:320/6/1_Antimicrobial-agent:infants-to-mothers-exposed-to-cephalosporins_vs_infants-to-mothers-unexposed-to-intrapartum-antibiotic_DOWN	NA	1678
bsdb:321/1/1_Antimicrobial-agent:10-d-old-7-10-day-treatment-infants_vs_10-d-old-2-day-treatment-infants_DOWN	NA	816	1357
bsdb:322/1/1_Oral-mucositis:patients-with-newly-diagnosed-malignancies_vs_reference_UP	NA	46123	1357	203697
bsdb:322/1/2_Oral-mucositis:patients-with-newly-diagnosed-malignancies_vs_reference_DOWN	NA	1716	346096	1378	848	22	2745	713
bsdb:322/2/1_Oral-mucositis:oral-mucositis_vs_no-oral-mucositis_UP	NA	1016	1357	146
bsdb:322/3/1_Oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	1279
bsdb:322/3/2_Oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_DOWN	NA	203697
bsdb:322/4/1_Oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	338
bsdb:322/5/1_Oral-mucositis:mucositis-lesions_vs_all-samples_UP	NA	46123	1654	1386	1357	196081	1279	1578	1257	40323	2093
bsdb:322/5/2_Oral-mucositis:mucositis-lesions_vs_all-samples_DOWN	NA	713	416916	724
bsdb:323/1/1_Necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1485	1279
bsdb:323/1/2_Necrotizing-enterocolitis:NEC_vs_non-NEC_DOWN	NA	28196	150022	29330	1654	286	59732	283	1301	1716
bsdb:323/3/1_Necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1279
bsdb:324/1/1_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_UP	NA	207244	33042	561	1505657	570	1578	620	1301	292632	191303	1357	239759
bsdb:324/1/2_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_DOWN	NA	1283313	816	1506553	158846	33024	838	841
bsdb:325/1/1_Psoriasis:psoriasis_vs_healthy-controls_UP	NA	572511	1263	216851	1678	33042	86331	189330	990721	1654	102106
bsdb:325/1/2_Psoriasis:psoriasis_vs_healthy-controls_DOWN	NA	574697	35832	283168	375288	838	40544	28050	577309
bsdb:326/1/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_UP	NA	239759	816	1392389	838
bsdb:326/1/2_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_DOWN	NA	572511	838
bsdb:326/2/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	239759	572511	946234	1392389	1263
bsdb:327/1/1_Antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_UP	NA	1578
bsdb:327/1/2_Antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_DOWN	NA	561	1301
bsdb:327/2/1_Antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment---week-2_vs_control(no-treatment)---week-2_UP	NA	1350
bsdb:327/3/2_Antimicrobial-agent:infants-received-long-term-(>5days)-antibiotic-treatment---week-1_vs_infants-received-short-term-(<3days)-antibiotic-treatment---week-1_UP	NA	29465
bsdb:328/1/1_Psoriatic-arthritis:psoriatic-arthiritis_vs_healthy-controls_DOWN	NA	239934	33042	46205	1263
bsdb:328/2/1_Psoriatic-arthritis:skin-psoriasis_vs_healthy-controls_DOWN	NA	375288	100883	33042
bsdb:328/3/1_Psoriatic-arthritis:psoriatic-arthiritis_vs_skin-psoriasis_UP	NA	100883
bsdb:329/1/1_Antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/1/2_Antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/2/1_Antimicrobial-agent:IAP-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/3/1_Antimicrobial-agent:IAP-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:329/4/1_Antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/4/2_Antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/5/1_Antimicrobial-agent:IAP+postnatal-antibiotic-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/6/1_Antimicrobial-agent:IAP+postnatal-antibiotic-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:330/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724	1257
bsdb:330/3/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	150022
bsdb:330/3/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724
bsdb:331/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	207244	572511	580596	33042	189330	1407607	724	1501226	841	1301	292632	1485
bsdb:331/1/2_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	816	216851	838	1283313	33024	1506553	375288	577309	1154586
bsdb:333/1/1_Antimicrobial-agent:infants-with-(Abx)_vs_without-(non-Abx)-use-of-maternal-antimicrobial-agents-at-delivery_DOWN	NA	1678
bsdb:334/1/1_Antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_UP	NA	1618113
bsdb:334/1/2_Antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_DOWN	NA	1678
bsdb:334/2/2_Antimicrobial-agent:infants-exposed-to-antibiotic->7day-(H-group)_vs_infants-exposed-to-antibiotic-<=7day-(L-group)_DOWN	NA	1678
bsdb:336/1/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_UP	NA	816	1578	13687
bsdb:336/1/2_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_DOWN	NA	1485
bsdb:336/4/1_Antimicrobial-agent:piperacillin-tazobactam-group-(postnatal-day-7)_vs_Antibiotic-free-group-(postnatal-day-7)_UP	NA	816	1350
bsdb:336/4/2_Antimicrobial-agent:piperacillin-tazobactam-group-(postnatal-day-7)_vs_Antibiotic-free-group-(postnatal-day-7)_DOWN	NA	570
bsdb:336/5/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_piperacillin-tazobactam-group-(postnatal-day-3)_DOWN	NA	1350
bsdb:336/6/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-7)_vs_piperacillin-tazobactam-group-(postnatal-day-7)_DOWN	NA	1485
bsdb:337/1/1_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1407607	1350
bsdb:337/1/2_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	816	1279	1301	29465
bsdb:337/3/1_Antimicrobial-agent:12-month-old-infants-exposed-to-antibiotics-during-the-second-trimester_vs_12-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1485	29465
bsdb:337/3/2_Antimicrobial-agent:12-month-old-infants-exposed-to-antibiotics-during-the-second-trimester_vs_12-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	239934	239759	816	572511	1485	204475	1506553	29465
bsdb:338/1/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	216851	724	28050	158846	33024
bsdb:338/1/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	39948	119852
bsdb:338/2/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	713	416916	194	848	117563	724	28050	158846	33024	32207	1301	40544	191303	29465
bsdb:338/2/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	447020	239759	244127	1678	35832	990721	1485	102106	1185408	872	1730	1769729	61170	119852	846	838	1263	44748
bsdb:340/1/1_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_UP	NA	469	10	629	100883	561	586	84108	29465
bsdb:340/1/2_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_DOWN	NA	773	189330	2745	1253
bsdb:341/1/1_Smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smoked_vs_never-smoked_UP	NA	32207	1301	29465
bsdb:341/2/1_Smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smokes_vs_never-smoked_DOWN	NA	482	838
bsdb:342/1/1_Asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-asthma-exacerbation_DOWN	NA	724
bsdb:342/2/1_Asthma:Samples-with-any-rhinovirus-infection_vs_Samples-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/2/2_Asthma:Samples-with-any-rhinovirus-infection_vs_Samples-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/3/1_Asthma:Samples-with-rhinovirus-A-(RV-A)_vs_Samples-that-were-RV-A-negative-_UP	NA	724	1301
bsdb:342/3/2_Asthma:Samples-with-rhinovirus-A-(RV-A)_vs_Samples-that-were-RV-A-negative-_DOWN	NA	1279
bsdb:342/5/1_Asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-exacerbation_UP	NA	475
bsdb:342/5/2_Asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-exacerbation_DOWN	NA	1651	1716	724	1279
bsdb:342/7/1_Asthma:samples-with-any-rhinovirus-infection_vs_samples-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/7/2_Asthma:samples-with-any-rhinovirus-infection_vs_samples-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/8/1_Asthma:Samples-with-rhinovirus-A_vs_Rhinovirus-negative-samples_UP	NA	724	1301
bsdb:342/8/2_Asthma:Samples-with-rhinovirus-A_vs_Rhinovirus-negative-samples_DOWN	NA	1279
bsdb:343/1/1_Leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_UP	NA	816	239934	216851
bsdb:343/1/2_Leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_DOWN	NA	1485
bsdb:344/1/1_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-blank-filter_UP	NA	946234	848	459786
bsdb:344/1/2_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-blank-filter_DOWN	NA	1386	80865	173479	55968	248038	283168	286	970	13687	1301
bsdb:345/1/1_Response-to-diet:Female-hamsters-LPD-group_vs_Female-hamsters-NPD-group_UP	NA	2086	816	156973	690621
bsdb:345/1/2_Response-to-diet:Female-hamsters-LPD-group_vs_Female-hamsters-NPD-group_DOWN	NA	469	174708	308865	204475	1159323	264147	248038	2093	217063	119852	146	577309
bsdb:345/3/1_Response-to-diet:Offspring-hamsters-LPD-group_vs_Offspring-hamsters-NPD-group_UP	NA	222991	2086	1663	1678	517	990721	1485	308865	1578	264147	248038	267929	133925	286	83618	577309
bsdb:345/3/2_Response-to-diet:Offspring-hamsters-LPD-group_vs_Offspring-hamsters-NPD-group_DOWN	NA	580596	189330	204475	28050	415014	1263	44748	872	209	29521	146	157
bsdb:345/4/1_Response-to-diet:Offspring-hamsters-niacin--group_vs_Offspring-hamsters-naicin+-group_UP	NA	146	415014
bsdb:345/4/2_Response-to-diet:Offspring-hamsters-niacin--group_vs_Offspring-hamsters-naicin+-group_DOWN	NA	222991	1663	241189	69965	248038	577309	1485
bsdb:346/2/1_Unipolar-depression:moderate-depression_vs_mild-depression_UP	NA	946234
bsdb:346/3/2_Anxiety-disorder:severe-anxiety_vs_mild-anxiety_DOWN	NA	1847725
bsdb:346/4/1_Anxiety-disorder:moderate-anxiety_vs_mild-anxiety_UP	NA	84111
